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 Abstract 
Diabetes mellitus is a growing health problem worldwide. Suitable long-term control 
and management of this disease are enabled by determination of glycated haemoglobin 
(HbA1c) in blood. The results are given as %HbA1c of total haemoglobin. Presently 
available tests vary in cost and convenience and there is an identified need to introduce 
improved equipment for self-monitoring. This dissertation focuses on fast and 
straightforward detection of glycated haemoglobin (HbA1c) using cyclic voltammetry 
and chronoamperometry. Haemoglobin was determined by monitoring its reaction with 
potassium ferricyanide on screen printed electrodes at an oxidative potential +500 mV. 
A working electrode was modified with carbon nanotubes to enhance electron transfer. 
A calibration curve was linear in a range from 0.83 to 83 mg/mL. Another innovative 
approach to detecting haemoglobin using its enzymatic activity was also developed. 
Detection of haemoglobin was performed with hydroquinone and hydrogen peroxide on 
screen printed electrodes at a potential -400 mV in a Flow Injection Analysis system 
(FIA). It enabled fast detection and amplification of electrochemical signals. 
Haemoglobin was detected in a range from 0.05 to 2 mg/mL. Also interferences caused 
by oxidation of substances such as ascorbic acid, uric acid, and acetaminophen present 
in blood were minimised at a reduction potential. Further work included the 
development of selective receptors for glycated haemoglobin (HbA1c). Aminophenyl 
boronic acid was polymerised on screen printed electrodes and on microplates in the 
presence of haemoglobin (imprinted polymer) or without protein (non-imprinted 
polymer). Improved binding of haemoglobin was obtained on an imprinted polymer as 
compared to a non-imprinted polymer which indicates the imprinting effect. 
Determination of glycated haemoglobin (HbA1c), in blood and control samples was 
also combined with chromatographic separation of total glycated haemoglobin and its 
further electrochemical detection. Results verified against spectrophotometric detection 
showed a good correlation with R
2
 = 0.9945.   
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 Aim and objectives of the project 
The goal of the project was to design a sensor for a fast and straightforward 
determination of glycated haemoglobin (HbA1c). 
 
The first task of the project was to detect haemoglobin using electrochemical methods. 
Further work was focussed on the recognition of glycated haemoglobin (HbA1c) 
separately and in its mixture with different types of haemoglobin. The studies included 
research of molecularly imprinted polymers, boronic acid derivatives and their 
integration with an electrochemical sensor. 
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SECTION I: LITERATURE REVIEW 
Chapter 1: Haemoglobin properties and determination of glycated 
haemoglobin in diabetes 
1.1 Introduction 
Diabetes mellitus is a disease characterised by an excess of glucose in blood and tissues 
as a result of insulin deficiency or/and insulin resistance. Type I diabetes (15% of all 
diabetes cases) and the most common Type 2 diabetes (85% of all cases) are caused by 
interplay of genetic and environmental factors. Most cases of diabetes are caused by 
obesity and physical inactivity and are on rise due to population ageing and 
urbanization. It can lead to vascular disease, such as stroke, blindness, renal failure, 
heart attack and circulatory insufficiency (Tuch et al., 2000; Watkins, 2003). 
Worldwide projections suggest that the total number of people with diabetes will rise up 
to 366 million in the year 2030. Health care costs due to diabetes are estimated to 
amount to about 14% of the total health care budget (Wild et al., 2004). The disease 
formulation is very complex and depends on many factors and this complexity partly 
explains why there is still no cure available. Correct treatment depends on frequent 
estimation of glucose in blood and the periodic determination of glycated haemoglobin 
(HbA1c).  Glucose measurement is important for setting insulin dosage, food intake and 
exercise. Most glucose meters measure glucose in a blood sample collected from a 
finger or arm using a lancet. Usually glucose measurements are performed 2-4 times per 
day, however higher frequency may be required. Unfortunately, it is possible to miss 
reoccurring high or low blood sugar levels. Therefore, attempts to develop an “artificial 
pancreas” have been undertaken. Sensors measuring glucose in vivo have been 
introduced onto the market. Medtronic offer a continuous glucose monitoring system 
(CGMS) alongside an insulin pump. Another suggested advantage of this approach is 
painless measurement of glucose and insulin delivery. However, it is necessary to 
implant the sensor under the skin of the abdomen. The use of this device may vary the 
detected level of HbA1c when compared with finger-sticks (Tuch et al., 2000; 
http://www.minimed.com access 07.05.2010). Measurement of HbA1c is the optimal 
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integrated indicator of glycemic control in diabetic patients and important for long-term 
control. Glucose passes easily into erythrocytes and therefore the rate of formation of 
glycated haemoglobin is directly proportional to the concentration of glucose in blood.  
Because the lifetime of red blood cells is around 120 days, evaluation of glycated 
haemoglobin reflects an average glucose concentration during this period (Hoffbrand et 
al. 2001). The American Diabetes Association recommends that physicians measure 
HbA1c at least twice a year in diabetic patients with stable glycemic control. Where 
control is unstable or if therapy has been changed, it is proposed to test more frequently 
(http://www.diabetes.org/ada access 07.05.2010). 
 
Tests which are currently used for HbA1c determination vary in cost, convenience and 
performance. Market is dominated by laboratory testing, blood samples have to be 
collected and tested in a hospital laboratory. More convenient is Point of Care (POC) 
technology. It is possible to collect a blood sample at home and send to the laboratory or 
HbA1c test could be performed and interpreted in a physician’s office. POC devices 
such as Bayer DCA 2000, Cholestech GDX, Metrika and Axis-Shield Nycocard HbA1c 
are available on the market. However, results may be imprecise due to difficulties in 
operating those devices, for example GDX and Nycocard devices require to perform 
several manual steps to estimate content of HbA1c (John et al., 2006). There is still a 
case for introducing equipment for self-control. Therefore, production of an affordable 
HbA1c sensor or its integration with a glucometer, suitable for home use would be 
highly desirable for the market. This can improve a person’s life and decrease institution 
health care cost.  
1.2 Haemoglobin structure and properties 
The major component of normal adult blood is haemoglobin type A. This molecule is a 
tetramer which is composed of two α and two β protein subunits which are made of 141 
and 146 amino acid residues, respectively. All proteins are noncovalently bound by salt 
bridges, hydrogen bonds and hydrophobic interaction and form quaternary structure. 
Interactions between α and β subunits are responsible for allosteric properties of 
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haemoglobin (α1β1, α2β2). Each subunit is associated with one non-protein heme group 
which is shown in Figure 2 (Stryer, 2006). 
 
 
 
 
 
Figure 1. 3-dimensional structure of HbA. The four subunits are shown in red and green 
with heme groups, hexapeptide on β-chain in blue 
(www.rcsb.org./pdb/explore.do?structureId=1GZX access 08/05/2010) 
 
 
 
Figure 2. The structure of haem group (Hoffbrand et al., 2001) 
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The heme group consists of a protoporphyrin and a central iron ion, normally in the 
ferrous (Fe
2+
) oxidation state which can form two additional coordination bonds. The 
iron atom is bound to four pyrrole nitrogen atoms and also to the protein via a histidine 
residue, precisely by its imidazole ring (Stryer, 2006). The total molecular weight of 
haemoglobin is about 68 kDa (Hoffbrand et al., 2001).  
 
Different types of normal and abnormal haemoglobin are listed in the Table 1. Normal 
haemoglobin values are: 13.5 – 17.5 g/dL and 11.5 – 15.5 g/dL for males and females 
adults, respectively. Hb content is in a range 11 – 12 g/dL during pregnancy, 15 – 21 
g/dL for newborn children and 11 – 13.5 g/dL for children (Hoffbrand et al., 2001).  
 
Table 1. Types of haemoglobin  
Normal haemoglobin 
(content in blood %) 
 
HbA 
(96-98%) 
HbA2 
(2.5%) 
HbF 
(0.5-0.8%) 
HbA1 HbA0 (major) 
 
HbA1a HbA1b HbA1c 
non-
glycated 
glycated 
(2-4%) 
re
m
ar
k
s react with other 
carbohydrated 
than glucose 
glycated at 
N-terminal 
Val (β 
chain) 
 
glycated at  
ε-N-terminal 
Lys (α-chain) 
 
st
ru
ct
u
re
 α2 β2 α2δ2 α2γ2 
Hb is a tetramer. Two α globin chains are encoded by α globin genes (α1 and 
α2) located on the chromosome 16, while γ, δ, β chains are encoded by their 
respective genes (
Gγ, Aγ, δ, β) located on the chromosome 11. Polypeptides γ, δ 
and β show structural differences. 
Abnormal Hb 
 
 HbS HbE HbC HbD HbH  
 
Haemoglobin can undergo reversible and also irreversible modifications. This molecule 
is well known for its function of oxygen and carbon dioxide transport. It also acts as a 
buffer regulating the pH level of blood.  A sixth position can be reversibly occupied by 
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oxygen. One haemoglobin molecule can bind four oxygen molecules cooperatively. 
This event causes changes in quaternary structure, namely α1β1 and α2β2 dimers move 
with respect to one another. This site can be also occupied by other small ligands, such 
as CO. Methaemoglobin (MetHb) is able to bind strongly ions, such as CN
-
 and N
3-
. It is 
known that SH and NO blocking reagents react with cysteine residues at a position 93 
on the β-chain subunit (Scheller et al., 2005). Haemoglobin can also interact with 
another protein and direct (heterogeneous) electron transfer between these molecules is 
possible. Its also has catalytic activity, catalysing a dehalogenation reaction and 
reduction of hydrogen peroxide (Imai, 1999; Winterbourn, 1985). 
 
Haemoglobin has about 44 possible glycation sites which can react with glucose or 
derivatives and form different glycated haemoglobins. The most abundant type is 
HbA1c. 60 % of glycated haemoglobins are always a result of post-translational, non-
enzymatic reaction of glucose and N-terminal valine of the β-chain. The reaction 
proceeds in two steps. Firstly, aldimine compound (Schiff base) is formed in a fast, 
reversible reaction. After that, ketoamine is formed due to internal, Amadori 
rearrangement. The last process is slow and irreversible (Peacock, 1984; Miedema, 
2005). The resulting molecule does not have the ability to transport oxygen (Hoffbrand 
et al., 2001). 
 
 
Figure 3. The formation of HbA1c (Peacock, 1984). 
 
A useful property to distinguish HbA0 from HbA1c is their isoelectric points, which is 
6.972 and 6.935, respectively, and their different structure (Hempe et al. 1997).  
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1.3 Haemoglobin reduction / oxidation in human organism 
The iron atom participates in redox reactions and may be either in the Fe
2+
 or Fe
3+
 state. 
The process of oxygen binding is associated with the partial electron transfer from the 
ferrous ion to the oxygen. Oxygenated haemoglobin contains a structure of ferric ion 
(Fe
3+
) and superoxide anion (O
2-
). Some ligands are able to stabilize the ferric form for 
example CN
-
 and lead to a MetHb formation which is unable to transport oxygen. 
MetHb is a by-product of respiration but is efficiently reduced by enzymes, thus less 
than 2% of haemoglobin exists in the form of MetHb (Stryer, 2006). 
1.4 Influence of blood composition on Hb determination 
Blood consists of a fluid medium, plasma (55% of blood volume) and different types of 
cells such as erythrocytes containing haemoglobin, leukocytes and thrombocytes. Blood 
plasma is mainly composed of water (90%), but also contains many vital proteins 
including fibrinogen, globulins and human serum albumin and inorganic electrolytes. 
Blood serves as transport medium for glucose, lipids, amino acids, hormones, vitamins, 
enzymes, antibodies, metabolic end products (urea, ammonia, bilirubin, urobilinogen), 
carbon dioxide and oxygen (Stryer, 2006). 
1.4.1 Interferences during molecular recognition and electrochemical 
detection 
Electrochemical sensors can suffer from interferences caused by substances, such as 
ascorbate, urate and acetaminophen, which may be oxidised instead of haemoglobin. 
However, the concentration of species mentioned above is less than 10% of the Hb 
concentration (Chen et al., 2003; Turner et al., 1999). Measurements performed at 
reduction potentials may also minimize interferences. There is a possibility to reduce 
HbFe
3+
 (Shang et al., 2003) or HbO2 and thus avoid interferences caused by the 
oxidation of other electroactive species which are present in blood. Chen et al. (1998) 
proposed the following mechanism: 
 
HbFe
2+
 + O2               HbFe
2+
O2              HbFe
2+
 + H2O2 
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The reduction peak was estimated at potential -220 mV vs SCE on a bare glassy carbon 
electrode (GCE) containing 100 μM HbO2 in a buffer solution (Chen et al., 1998). Due 
to this reaction it could be possible to distinguish HbA1c from HbA0 since HbA1c does 
not bind the oxygen (Stryer, 2006). However, this solution seems to be impractical due 
to necessity to monitor precisely concentration of oxygen. Other potential interferents, 
such as human serum albumin can affect the Hb detection process. This molecule can 
interfere with the recognition step since the molecular mass (67 kDa) is similar to Hb 
and concentration of albumin is high, in a range 36 to 47 g/L in venous serum 
(Christopher et al., 1999). Research performed by Bossi et al. (2001) showed that 
compounds, such as serum albumin have influence on the HbA0 binding process. They 
found that the higher the addition of competitor, in that case bovine serum albumin 
(BSA), the lower is the absorption of HbA0 (Bossi et al., 2001). In other research, it 
was reported that it is possible to distinguish Hb from BSA due to different size and 
shape of these two proteins (Xia et al., 2005). Different studies utilising MIP to detect 
glycoprotein gp51 (bovine leukemia virus protein) showed a small influence of BSA 
towards the affinity of imprinted polypyrrole (Romanaviciene and Ramanavicious, 
2004). Also abnormal haemoglobins and derivatives may interfere and produce a 
different signal in charge-dependent methods. In separation carbamylated and acetylated 
haemoglobin may co-migrate with HbA1c and HbA2 may be eluted with HbC (Hempe 
et al, 1997).  
1.5 Reference method for determination of glycated haemoglobin 
(%HbA1c) 
The A1C test is given as a percentage of haemoglobin that is glycated at N-terminal 
valine of β chain to the total content of haemoglobin. It is a useful index of glycaemic 
control and reflects the management of diabetes for the preceding 120 days. HbA1c 
values between 4-6% are considered as normal. People with diabetes are advised to 
keep their level of HbA1c below 7%, but the exact figure can be different for each 
method. Also, target value of HbA1c depends on health condition and age of diabetics. 
A target range may indicate acceptable values for a person with diabetes and this may 
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differ from the normal range seen in the non-diabetic population (Watkins, 1998; Silink 
and Mbanya., 2007). 
 
Methods for separation of glycated haemoglobins are based on differences in their 
electric charge, molecular structure or immunological reactivity. Current measurements 
of HbA1c are based on three main assay principles, namely cation exchange 
chromatography, affinity chromatography and immunoassays. Affinity chromatography 
has minimal interferences resulting from hemoglobinopathies, carbamylated Hb and 
sample degradation problems as compared to the ion-exchange, electrophoresis or 
immunoassay methods. HPLC technique gives high precision and permits fast 
separation of HbA1c from HbA0 and the other minor components. It is very important 
to choose right reference method for all studies (Gallagher et al., 2009; 
http://www.ngsp.org/docs/methods.pdf access 05/05/2010).  
 
In the past there has been a concern regarding a lack of standardisation. Measurements 
of glycated haemoglobin from different laboratories have not been easily compared.  
Presently many laboratories provide test that correlates well with the Diabetes Control 
and Complications Trial studies (DCCT, 1993). New methods are verified with National 
Glycohemoglobin Standardization Program (NGSP) which uses a reference method 
developed by Diabetes Control and Complications Trial, the BioRad Diamat (HPLC 
cation exchange chromatography). International Federation of Clinical Chemistry 
(IFCC) which established an international standardization program recommends two 
reference methods, HPLC-MS or HPLC-CE. Measurement is based on determination of 
the glycated terminal hexapeptide, cleaved from the haemoglobin molecule (Miedema, 
2005; Gallagher et al. 2009). Another reference method can be compared with IFCC 
method. Complete list of methods and laboratories validated with NGSP standards can 
be found on NGSP website (http://www.ngsp.org/certified.asp, accessed 05.05.2010). 
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Chapter 2: Biosensor / sensor technology 
Chemical sensors consist of a sensitive layer reacting with analyte and a transducer, 
which converts the binding event into a quantifiable output signal. The recognition 
element has a significant influence on selectivity, while the transducer mainly 
determines sensitivity. Biological materials such as enzymes, antibodies, tissue 
fragment and cells are frequently used as a recognition element in biosensors. However 
the application of biomaterials may be limited because of low stability and laborious, 
time-consuming and expensive production (Jankiewicz, 2001).  
 
 
Figure 4. Scheme of biosensor (modified from Jankiewicz, 2001). 
2.1 Transducer 
The most frequently used transducers are electrochemical (for example potentiometric, 
amperometric, conductometric), piezoelectric (QCM) and optical (for example SPR, 
fluorescent, evanescent field devices). The most common in biosensors are 
amperometric transducers. Their construction is relatively uncomplicated which 
provides experimental simplicity and cost efficiency necessary in commercialisation 
(Law et al., 2002).  Amperometric, QCM and SPR transducers have already been tested 
for haemoglobin detection and examples will be presented in the review. 
 
 
signal 
recording 
and processing 
biological recognition 
element transducer 
analyte 
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2.1.1 Electrochemical techniques 
Potentiometric and voltammetric techniques are often used as diagnostic tools. 
Voltammetric techniques include: cyclic voltammetry (CV), linear sweep voltammetry 
(LSV), normal pulse voltammetry (NPV), differential pulse voltammetry (DPV), square 
wave voltammetry (SWV), anodic stripping voltammetry (ASV), cathodic stripping 
voltammetry (CSV), adsorptive stripping voltammetry (AdSV), polarographic 
techniques, chronoamperometry and chronocoulometry.   
 
Electrochemical methods provide a direct relation between the electrical signal 
measured and the concentration of species in solution. In most cases equipment is not 
sophisticated and precise, fast measurement can be provided (Higson, 2003; Bilitewski 
and Turner, 2000). The majority of commercial biosensors are based on the 
electrochemical transducers, where the electrochemical cell consist of a working 
electrode (WE), reference electrode (RE) and counter electrode (CE). Electrodes 
commonly used are the silver/silver chloride for the reference electrode, carbon as a 
working electrode and carbon or platinum as a counter electrode. Current is measured 
following application of a potential difference between the working electrode and 
reference electrode and results from the oxidation or reduction of analyte on the 
working electrode.  
 
Cyclic voltammetry is a very useful method for fast characterisation of redox reactions 
occurring on the electrode surface. This method can be also used to determine a 
concentration of reduced or oxidized species. Also a diffusion coefficient of 
electroactive substances can be determined. Voltage is changed linearly with time and 
oscillates between two switching potentials. Redox system is characterised by position 
of oxidation (Epa) and reduction peak (Epc), their separation (∆Ep), midpotential (Em), 
and current density (j). Reversible reaction can be characterised under diffusion mass 
transport control by parameters such as: peak separation 0.059 V for one electron 
reaction and 0.0295 V for two electron reaction. Furthermore peaks position do not alter 
with a different scan rate, a ratio of anodic and cathodic peak current is equal to 1 
(ipa/ipc=1). Peak current is proportional to square root of scan rate 
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Figure 5. Cyclic voltammogram of reversible system (Brett and Brett, 1998) 
 
Scan rate has a significant influence on shape of CV and is particuraly important for 
studies different coupled chemical reactions. For example, an electrochemical reaction 
may be reversible or not at different scan rate. Chemical reaction may not be observable 
at high scan rate. Furthermore scan rate should be considered particularly when an 
analyte concentration is very low since it has an influence on a charging current. 
Influence of background current is increased with higher scan rate. It is associated with 
faradaic and also with non-faradaic current, namely charging current between electrode 
and electrolyte (Eggins, 2002). 
 
Chronoamperometry is very useful to evaluate an analyte concentration. Measurements 
are performed at a controlled potential where an electroactive substance undergoes a 
reduction or oxidation reaction. If a process is under diffusion control without an effect 
of convection and migration, and the electrode is relatively large and planar, the current 
is governed by the Cottrell equation:  
 
i=nFAD
1/2
COx/π
1/2
t
1/2
 
 
where, i is the current, n the number of electrons transferred per molecule, A is the 
electrode surface area, D is the diffusion coefficient, COx is the substrate concentration, t 
is the time.  
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Reactants decrease near the electrode with time and create a diffusion layer. The current 
decreases with a square root of time. The current density strongly depends on mass 
transfer at a high overpotential and is independent of mass transfer at a low 
overpotential. The rate of the process is determined by the electron transfer at a low 
overpotential. 
 
Experiments can be carried under conditions where a mass transfer is mainly caused by 
diffusion. A solution is not stirred and an electrode is not moved since it is important 
not to perturb the system. To avoid natural convection it is necessary to reduce 
timescale of experiment. However data can be distorted by an influence of charging 
current which is high at the beginning of measurement. The second type of experiments 
involves a controllable form of convection. It can be achieved by application of the 
rotating disc electrode. The same effect can be obtained in a flow system. A test 
solution flows through a channel in which there is placed a planar electrode. Two 
different configurations, such as thin-layer and wall-jet flow cells are commonly used.  
The migration is reduced by addition of an inert electrolyte (Pletcher, 1991; Wang, 
2006). Figure 6 shows a current density versus time under different type of control. 
 
  
Figure 6. Current density versus time at a) diffusion control b) mixed control and c) 
electron transfer control (Pletcher, 1991). 
 
Potentiometric sensors rely on monitoring a potential at zero current, which is expressed 
by the Nernst equation: 
 
E=E°+2,303 RT/nF log10([Ox]/[R]) 
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where, E° is the standard redox potential, R is the gas constant (8.314 J/molK), T is the 
temperature, n is the number of electrons exchanged in reaction, F is the Faraday 
constant (96500 C/mol), Ox and R are the concentration of oxidised and reduced form 
of reagent (Eggins, 2002). 
 
The important types of electrochemical sensors are ion-selective electrodes with 
example of ion-selective field effect transistors (ISFET). ISFETs are devices in which a 
transistor amplifier is used as a miniature transducer. They are used for measurement of 
potentiometric signals, which are produced on the gate (metal) of the FET. The gate is 
coated with a chemically sensing surface or an ion-selective membrane (Wang, 2006).  
 
In many cases it is necessary to modify the electrode since compounds such as proteins 
cause a passivation of electron flow after being immobilised directly on the electrode 
surface (Brett et al., 1999; Hart et al., 2003). In recent years there has been interest in 
using different modifications of electrode surfaces employed to achieve better electron 
transfer and catalytic activity of Hb and other compounds. 
2.1.2 SPR and QCM 
Detection of binding process can be also realised using surface plasmon resonance 
(SPR) technique. Surface plasmons are formed in the boundary of a solid (for example 
metal). Electrons behave like a quasi-free electron gas. Exterior electrical fields in the 
boundary produce quanta of oscillations of surface charges with high-frequency 
electromagnetic fields. These plasmons can be excited by light or by electron beams. 
SPR is one of the most often exploited reflection technique. In one basic configuration, 
a quartz prism is covered on one surface by thin layer of metal for example silver or 
gold. A ligand film, able to bind an analyte, is coated on the metal surface. SPR 
reflectivity measurements can be used to detect proteins by the changes in the refractive 
index due to adsorption of the target molecule to the metal surface. This technique has 
been widely exploited in affinity biosensors (Law et al., 2000). SPR technique was used 
to detect haemoglobin in blood sample by Yuk et al. (2007). They studied interaction 
between haptoglobin (Hp) and haemoglobin (Hb). Solution of mercaptoundecanoic acid 
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and mercaptohexanol were used to modify gold arrays. Significant interaction was 
observed when haptoglobin or antibodies were used as ligands against Hb (Yuk et al., 
2007). 
 
A quartz crystal microbalance (QCM) measures mass by measuring the change in 
frequency of a piezoelectric quartz crystal when it is disturbed by the addition of an 
analyte. Its behaviour is explained by the Sauerbrey equation:  
 
∆f = -2.3 x 106 f2 ∆m/A 
 
where, f is the overall resonant frequency, ∆m is the mass of the adsorbed materials, A 
is the surface of a sensing region 
 
It is useful to determine adhesion of proteins using frequency measurements with a high 
precision (Jankiewicz, 2001). Biosensors based on QCM transducer allow label-free 
determination of kinetic parameters of affinity interactions. This type of transducers was 
successfully used to estimate HbA1c. A self-assembled monolayer of 
aminophenylboronic acid (APBA) was directly deposited on the activated surface of a 
QCM transducer. The sensor was found to have a linear response in the range from 0.5 
to 2.0 mg/mL. Thus it could be useful in HbA1c analysis since the values are close to 
physiological levels (Pribyl and Skladal, 2004). Further research using a combination of 
the piezoelectric sensor for HbA1c and a flow-through photometric sensor for total 
haemoglobin determination also showed good results. The detection ranges of total and 
glycated haemoglobin (HbA1c) were 0.05–2.0 mg/mL (R.S.D. 3%) and 0.01–0.090 
mg/mL (R.S.D 12%), respectively. The calibration was made for a standard solution, 
not a real blood sample (Pribyl and Skladal, 2006). 
2.2 Electrochemical properties and detection of haemoglobin 
The main problems in electrochemical studies of Hb are slow electron transfer, poor 
signal and electrode passivation. This is due to the large 3-dimensional structure of Hb 
and hidden heme group inside the molecule, which results in inaccessibility of heme 
group (Hart et al., 2003). Other difficulties concern the amount of electroactive protein, 
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denaturation (Yan et al., 2005) and unfavourable orientation of haemoglobin at the 
electrode surface (Yin et al., 2006). 
2.2.1 Mediated sensor 
Numerous studies have been conducted using a mediator to facilitate electron transfer in 
biosensors. Commonly used mediators are ferrocene and its derivatives, ferricyanide, 
N,N,N
’
N
’
-tetramethyl-p-phenylenediamine (TMPD) and osmium complexes (Turner et 
al., 1987; Reiter et al., 2001). Their application can also reduce possible interferences 
from substances present in blood samples by reducing the potential required to monitor 
the reaction. For instance, ascorbic acid has a redox potential more positive than 0 V vs 
Ag/AgCl on a pyrolytic graphite (PG) electrode and at a lower potential it is 
electroinactive (Liu et al., 2004). All the most successful home blood glucose 
monitoring companies now use mediated electrochemistry (Turner et al., 1999).  
 
The electrochemical response in the presence of Hb on an electrode with a mediator, 
such as ferricyanide results from the oxidation of the heme group and reduction of the 
mediator. Oxidation of the reduced mediator produces current flow which is 
proportional to the amount of haemoglobin (Son et al., 2006).  
 
Figure 7. The mechanism of electrochemical detection of haemoglobin using a 
mediator. RBC-red blood cell (Son et al., 2006). 
 
Jiang et al. (2005) also prepared a haemoglobin sensor using potassium ferricyanide 
(100 mM) in the solution. Studies were performed on two-electrode system, based on 
thin-film technology. The plastic substrate (0.5 mm x 6 mm x 1 mm) was coated with 
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NiCr/Au film (10 nm / 100 nm thickness) and afterwards electrodes were coated with 
carboxymethyl cellulose to form a hydrophilic membrane. Sensor response was studied 
with an amperometric method at the working potential of +200 mV. Authors suggested 
the catalytic mechanism as follows. 
 
HbFe
2+
 + Fe(CN)6
3-
                    Fe(CN)6
4-
 + HbFe
3+
 
Fe(CN)6
4-
                     Fe(CN)6
3-
 + e
- 
 
The first chemical reaction suggests that the process is irreversible. The calibration 
curve for the sensor was in the linear range of 10 – 3000 μM, which correlate well with 
clinical demand of 1600 – 2400 μM. The experiment was performed over 280 seconds 
and Hb was added to the mediator solution after 50 seconds. The correlation coefficient 
was 0.996 and standard deviation 2.3% for six measurements (2000 μM Hb). The 
response time of the sensor was 90 seconds and the detection limit for the sensor was 5 
μM (Jiang et al., 2005). They also showed detection of Hb using methylene blue as a 
mediator. A three-electrode system, which was used in the studies, consisted of a 
working electrode, Ag/AgCl as a reference electrode and platinum as a counter 
electrode. A cyclic voltammogram was performed at a scan rate 100 mV/s from 0 to -
400 mV. The anodic peak potential was recorded at the potential -200 mV. The linear 
range was lower than in the previous experiment (from 0 to 200 μM).  
 
A carbon electrode modified by ferrocene carboxylic acid (FcCOOH) was developed by 
Chen et al. (2003) who used a chronoamperometric method for the measurement of Hb 
in blood samples. The sensor was operated at +400 mV versus Ag/AgCl 
(reference/counter electrode). The authors reported a fast response with Hb solution and 
plateau after 10 seconds. The measurement time was less than 1 minute. Linearity was 
obtained with concentration of Hb up to 93 μM. Therefore, real blood sample with 
much higher level of haemoglobin required to be diluted. This step can also minimise 
possible interferences. It was reported that the amount of FcCOOH had an influence on 
sensitivity. A 1:1 ratio of carbon: FcOOH was chosen for electrode fabrication. The 
variation coefficient was 8.6% with n=10. The sensor could not be used many times 
because of mediator leaching out in a wash step (Chen et al., 2003). 
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Determination of haemoglobin (HbFe
2+
) via its electrooxidation have been carried out 
on modified poly(methylene blue) electrodes. The electrochemical cell consisted of a 
glassy carbon electrode, SCE reference electrode and a platinum counter electrode. 
Tests were done using chronoamperometric methods with a potential of +550 mV vs 
SCE. Positive results were obtained with human whole blood samples (dilution 1:5), but 
not with commercial Hb at this potential; perhaps because commercial Hb is almost 
100% MetHb. A standard deviation of 5% for n=3 was obtained (Brett et al. 1999). 
2.2.2 Mediator-free sensor 
Direct electron transfer between haemoglobin and an electrode is another approach. 
Construction of sensors without a mediator is based on application of nanoparticles, 
polymers and other materials. HbA0 / HbA1c detection is possible due to their 
properties and material characteristics. They play a role not only in electrochemistry, 
but also in providing analyte recognition matrices, which will be discussed in the next 
sections.  
 
Metal nanoparticles have good conductivity and catalytic properties.  They can decrease 
overpotentials of electrochemical reactions and promote the reversibility of some redox 
reactions. Nanoparticles play a role in immobilisation without a loss of bioactivity (Luo 
et al., 2005). They can modify biological material or form nanotubes or nanowires on 
the electrode surface (Murphy, 2006). Nanoparticles have recently been more often used 
to enhance electron transfer between redox centres in haemoglobin and electrode 
surfaces. Their application is presented below. 
 
Liu et al. (2006) studied direct electrochemistry of haemoglobin with cyclic 
voltammetry on zirconium dioxide (ZrO2) nanoparticles in the presence of 
didodecyldimethylammonium bromide (DDAB). The electrochemical cell contained a 
platinum auxilary electrode and an Ag/AgCl reference electrode. Immobilisation of 
haemoglobin on particles showed a faster electron transfer 149s
-1
  in comparison with 
Hb immobilised in DDAB solution (2.3+-0.4 s
-1
) (Lu et al., 1997), ZrO2/DMSO (7.9+-
0.93s
-1
) or in clay colloid nanoparticles (79s
-1
) (Lei et al., 2002). Application of 
nanoparticles was used for determination of HbA1c. For this purpose researchers used 
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ZrO2/DDAB nanoparticles, a pyrolytic graphite modified electrode (PG) and 
ferroceneboronic acid (FcBA). Ferroceneboronic acid was used for the recognition and 
detection of HbA1c. Recognition of HbA1c was possible due to specific affinity of 
boronic group to glucose. Ferroceneboronic acid is also electroactive compound and 
therefore it was possible to detect HbA1c with electrochemical methods (square wave 
voltammetry). Haemoglobin was immobilised onto the particles and cast on the 
electrode. Then the electrode was incubated with FcBA solution and unbound FcBA 
was removed in a washing step. The electrochemical signal resulted from FcBA bound 
to HbA1c. This could be explored to distinguish between Hb and HbA1c. It was 
calculated that only 4.6% of immobilised haemoglobin was active electrochemically. A 
high deviation in comparison to the standard method of HPLC (from -10.7 to 31%) was 
observed by researchers (Liu et al., 2006).  Further improvement will be necessary for a 
precise measurement of HbA1c.  
 
Direct electron transfer was obtained by Han et al. (2002) using lipid (DDAB)-protected 
gold nanoparticles. They used a glassy carbon working electrode and a Ag/AgCl 
reference electrode. The formal potential was -169 mV vs Ag/AgCl. They showed that 
Hb can be adsorbed to nanoparticles keeping its natural activity. Most probably lipid 
provided the microenvironment for both electron transfer and immobilisation. Gold 
played a role as a link between haemoglobin and electrode. 
 
Another approach is to cover nanoparticles with antibodies specific to haemoglobin and 
its detection by stripping voltammetry. A preconcentration of an analyte on the 
electrode may improve a detection limit. Electrochemical metaloimmunoassay was used 
successfully for myoglobin determination showing promising results as compared to 
ELISA assay (Szymanski et al. 2009).  
 
Electron transfer and detection of analyte can be facilitated also by the application of 
carbon nanotubes. This probably results from their electrochemical and structural 
properties; the 3-dimensial structure and thus a larger surface area and a high 
conductivity (Yan et al., 2005).  
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Direct electron transfer can be also improved by the application strategies based on 
other surface modifications. For instance, polymers such as polyaniline and polypyrrole 
can act as an electrical wire or mediator and thus facilitate electron conduction. This 
property may be used to detect binding events by monitoring decrease or increase in 
electron transport. They can be also utilized as a matrix for the preparation of affinity 
materials (Kriz et al., 1995). Rick and Chou (2006) showed high conductivity of two 
polymer layers, namely poly-aminophenylboronic acid (APBA), formed on a 
polypyrrole. Current transmitting capacity was higher for this material than for a film 
made of p-APBA grafted directly on platinum.  
 
 
 
 
Figure 8. Structures of the monomers used and their polymeric forms. A) 3-
amionphenylboronic acid and B) pyrrole (Rick and Chou, 2006).  
 
Hart et al. (2003) combined an impregnated carbon-ink printed electrode 
(carbon/cyclohexanone) and a screen-printed carbon electrode for Hb measurement 
(lyophilised bovine haemoglobin). CV was run from -300 mV to +800 mV versus 
Ag/AgCl as a reference electrode. The authors also used an electron transfer promoter, 
cetyltrimethylammonium bromide (CTAB), with the analyte solution. The result was a 
quasi-reversible response in a presence of Hb. The voltammetric response for the 
cathodic and anodic signals was linear up to 8 and 4 mg/mL, respectively (lower than 
the values obtained by Chen et al. (2003) and Jiang et al. (2005)). There was no anodic 
or cathodic peak at a plain unmodified surface-printed carbon electrode with or without 
CTAB (Hart et al., 2003). 
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2.2.3 Catalytic activity 
Haemoglobin has catalytic activity because of its similarity with peroxidase (Shang et 
al., 2003). Numerous studies have been performed to construct HRP-based sensor for 
hydrogen peroxide detection. Figure 9 shows schematic presentation of sensor 
performance. 
 
 
Figure 9. Schematic representation of electrochemical detection of hydrogen peroxide. 
MEDox and MEDred are oxidized and reduced forms of mediator. HRPox and HRPred are 
the redox forms of HRP. 
 
Reactions catalyzed by HRP are as follows: 
 
 
The first reaction leads to a formation of an unstable intermediate which contains Fe
4+
 
and porphyrin-radical cation. This compound reacts with a reduced mediator and gives 
HRP with ferryl cation (Fe
4+
). The latter is reduced by a mediator to a native state of 
HRP containing Fe
3+
 (Schubert et al., 1991; Lei et al., 1996; Liu et al., 1996). Detection 
of redox reactions with a mediator allows minimization of the interferences. The current 
signal is proportional to the amount of oxidized mediator resulting from an enzymatic 
reaction. Hydrogen peroxide concentration can be also evaluated by the well-known 
direct detection of hydrogen peroxide onto the electrode by its oxidation or reduction: 
 
HRP Fe
3+
 + H202                      
HRP
+.
 Fe
4+
=0 + MEDred 
HRP Fe
4+
=0 + MEDred + 2H
+
 
HRP
+.
 Fe
4+
=0 + H20 
HRP Fe
4+
=0 + MEDox 
HRP Fe
3+
 + MEDox + H20 
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H2O2                     O2 + 2H
+ 
+ 2e
-
 
2H2O2 + 2H
+
 + 2e                   2H2O  
 
However, this approach can suffer from interferences from other electroactive species at 
high potentials, which are required to apply for direct electrochemical detection of H202 
(Desai et al., 1993; Stollner et al., 2002; Wang, 2006). 
 
The mechanism of Hb mediated catalytic activity towards hydrogen peroxide could be 
the same as for horseradish peroxidase. The reduced form of haemoglobin (HbFe
2+
) can 
also react with hydrogen peroxide. However, reaction between HbFe
4+
 and reduced 
mediator regenerates HbFe
3+
 and not HbFe
2+
 (Everse and Hsia, 1996).  
 
Masuoka et al. (2003) showed an enhanced and faster catalytic activity of haemoglobin 
and also methaemoglobin A in the presence of reduced pyridine nucleotides. Inhibition 
of catalytic reaction was caused by oxygen, carbon monoxide, sodium azide and 
potassium cyanide. They suggested that NAD(P)H could protect haemoglobin from 
oxidative degradation. The pH 4.5-5.0 was estimated as optimal, however reaction in a 
neutral condition was also confirmed. In the absence of reducing NAD(P)H, ferryl 
radical could oxidise another Hb molecule or other biomolecule. Such mechanism was 
described by Gulivi et al. (1990) and Winterbourn (1985). However, catalytic activity of 
haemoglobin was 43 times lower than catalase. This should be considered in the 
haemoglobin sensor. Masuoka et al. (2003) explained catalytic activity of Hb in vitro by 
following reactions: 
 
2H-HbFe
2+
O2 + H2O2 + 2H
+  
                 2H-HbFe
3+
 + H2O + O2 
H-HbFe
3+
 + H2O2                   HbFe
4+
=O + H2O + H
+
 
HbFe
4+
=O + NAD(P)H + 2H
+
                 H-HbFe
3+
 + NAD(P)
+
 + H2O 
 
Furthermore, interesting studies were performed by Storle and Eyer (1991). In reaction 
between oxyhaemoglobin (HbFe
2+
O2) (3 mM) and N,N,N
’
N
’
-Tetramethyl-p-
phenylenediamine (TMPD) (0.1 mM) they observed formation of ferrihaemoglobin 
(HbFe
3+
). Catalytic mechanism was also confirmed with human red blood cells (3 mM 
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Hb) which were incubated with TMPD (0.1 mM). The reaction rate was lower in the 
presence of catalase. Therefore, they claimed that this process was enhanced by 
hydrogen peroxide which was formed during the process. The oxidation of TMPD (0.1 
mM) with hydrogen peroxide (0.1 mM) was not observed. These researchers proposed a 
mechanism as follows: 
 
HbO2 + TMPD             HbFe
3+
 [- OO]
2-
 + TMPD
+. 
HbFe
2+
 + TMPD
+.
             HbFe
3+
 + TMPD 
HbFe
3+ 
[- OO]
2- 
+ 2H
+
             HbFe
3+
 + H2O2 
HbFe
2+
 + H2O2 …….  HbFe
3+
 + products 
 
They suggested that the superoxide radical anion plays a minor role in ferrihaemoglobin 
formation while hydrogen peroxide is a major player. This fact can reflect gradual 
formation of hydrogen peroxide which itself produces ferrihaemoglobin. These studies 
indicate possibility for application of TMPD in electrochemical detection of Hb (Storle 
and Eyer, 1991). 
 
Numerous studies have been dedicated to a catalytic activity of Hb including its 
application in biosensors. However, it has not been applied to detect haemoglobin using 
electrochemical techniques so far. This property has been applied to construct H202 
sensor. The signal was produced by a reduction of H202 and direct electrochemistry of 
Hb (Feng et al., 2005; Liu et al., 2005; Masuoka et al., 2003; Li et al., 2006). Catalytic 
activity and direct electron transfer have been also reported to detect substances such as 
O2, trichloroacetic acid and bromate (Li et al., 2006) and NO (Fan et al., 2004). These 
reactions may also be used to detect Hb, but their efficiency might not be sufficient for 
biosensor application. Materials that may be exploited to assist in catalytic activity of 
biomolecules include amphiphilic polymeric polyacrylamide, lipid bilayers and other 
films. They create more suitable environment for protein function and also may have a 
positive impact on the protein orientation and location close to the electrode surface 
(Davis and Higson, 2005). The following examples show the detection of catalytic 
activity by reduction of HbFe
3+
 on the electrode using various immobilisation 
techniques. 
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Shang et al. (2003) reported that Hb showed direct electron transfer and an increased 
peroxidase (reduction) activity after being captured in a DNA matrix. They used 
pyrolytic graphite (PG) as a working electrode, saturated calomel electrode (SCE) as a 
reference electrode and platinum as a counter electrode. The potential range of the CV 
was between +300 and -800 mV and the scan rate was 100-1000 mV/s. The last 
parameter had no influence on the peak shift. Key findings were the importance of pH 
on the CV (more acidic or basic pH gave higher peak). However, such conditions were 
not suitable for the stability of Hb-DNA (peak current was decreased about 25% after 
20 cycles of a scan at pH 3.0). pH 4.5 was estimated as optimal. The linear range was 
1.9x10
-6
-6.8x10
-4
 mol/L with a detection limit 1x10
-6
 mol/L (Shang et al., 2003).  
 
Enzymatic activity was also obtained after immobilisation of Hb on chitosan films. 
Electrostatic interaction enhanced the process and Hb was protected in this environment 
showing good biological activity. Therefore, it can be presumed that an immobilisation 
can have a protective effect on the protein structure and preserve it from unfolding 
(Zhang et al., 2006). 
 
Application of phospholipid bilayers appears to be an interesting approach as they are 
structural elements of biological membranes. Different types of phospholipid bilayers 
have been constructed, for example Langmuir-Blodgett films (Du et al., 2005; Davis 
and Higson, 2005). Lipid modified electrodes or surfactant for example polyions 
complex 2C12N
+
PSS
-
 with similar properties to a lipid membrane (7% Hb was 
electroactive) have also proved useful for improving protein activity. It was shown that 
film made from dimyristoyl phosphatidylcholine (DMPC) and Hb immobilised onto 
pyrolytic graphite forms an ordered multilayer structure. This construction facilitated 
faster electron transfer. It was confirmed that Hb retained a near native conformation 
and showed reduction of trichloroacetic acid (Yang and Hu, 1999). 
 
Yin et al. (2006) also showed that haemoglobin can be immobilised in a well-ordered 
form in a linoleic acid monolayer using the Langmuir-Blodgett technique (Hb-LA LB). 
It was found that LA facilitated electron exchange (∆Ep 80 mV) between Hb and gold 
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electrode and well-defined redox peaks were observed: Epa -180 mV, Epc -260 mV, E
o
 -
220 mV (vs Ag/AgCl). Such modified electrodes had an activity towards reduction of 
H2O2 with a linear range of 2.0-100.0 μM and a detection limit of 1.2 μM (Yin et al., 
2006). Similar performance could be achieved by encapsulation of haemoglobin in 
mesoporous silicas. This is a new possibility for the adsorption of large molecules since 
the size of the pores can be tailored to the size of host molecule. Mesoporous silicas 
have large surface area and ordered pore structures. The behaviour of Hb on silica is 
facilitated by coulombic attraction between negative charge on the surface and positive 
net charge of the protein (at pH 5.0). Direct electron exchange and enhanced electron 
transfer were achieved. However, significantly better results were obtained with gold 
particles on silicas. Well-defined and quasi-reversible cathodic and anodic peaks were 
visible on a cyclic voltammogram, with potentials of -60 mV and +70 mV vs saturated 
calomel electrode (SCE), respectively. Moreover, the latter experiment showed three 
times higher catalytic H2O2 reduction with a range 5.0x10
-6
-1.0x10
-2
 mol/L and a 
detection limit of 1.0x10
-6
 mol/L (Xian et al., 2006). 
 
Many reports discuss the catalytic role of haemoglobin on modified carbon nanotubes 
CNTs electrode (Zhao et al., 2005; Wang et al., 2005; Yan et al., 2005). 
 
Figure 10. Carbon nanotube, magnification 50000x (Li et al., 2006) 
 
Zhao et al. (2005) showed that Hb incorporated in carbon nanotubes had a reversible 
redox process at formal potential E
o
 -278 mV, peak separation: 119 mV, Epa -219 mV, 
Epc -338 mV, scan rate 20 mVs
-1
. The electron transfer rate constant (k) was estimated 
as 0.062s
-1
. Furthermore, Hb kept its native structure and showed catalytic activity 
toward H2O2 at CNT surface (at a potential of 0.8V). However, the detection limit 
needed to be improved in this case since it was relatively high: 9x10
-6
 mol/L. The linear 
response was in the range 2.1x10
-4
-9x10
-4
 mol/L (Zhao et al., 2005). 
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Fabrication of H2O2 biosensor was also performed by immobilisation of Hb on multi-
wall carbon nanotubes (MWNT) and gold colloidal nanoparticles (GNPs). It was based 
on electrostatic interaction between positively charged Hb and negatively charged 
particles. The layer Hb/GNPs was assembled on the layer of Hb/MWNT, previously 
arranged on a glassy carbon (GC) electrode. CVs of Hb/MWNT/GC and 
Hb/Au/Hb/MWNT/GC gave redox peak at -260 and -370 mV at a scan rate of 50 mV/s. 
The latter also showed a higher oxidation peak. Increasing amount of H2O2 caused a 
reduction peak increase and an oxidation peak decrease. Peak currents increased linearly 
with scan rate from 10 to 300 mV/s, which indicated a surface-controlled process. The 
pH 6.0 and potential -300 mV were chosen for optimal action of the sensor. Linear 
response was observed for concentrations 2.1x10
-7
 – 3.0x10-3 M H2O2 and response 
time 5 seconds. Possible interferences of uric acid, glucose and ascorbic acid were not 
observed. Prepared films showed good catalytic activity (Yan et al., 2005). 
 
Catalytic response was observed with H2O2 and NaNO2 on polyamidoamine (PAMAM) 
dendrimers films. PAMAM films seem to be suitable because their structures mimic a 
three–dimensional structure of bio-macromolecules and have a good biocompatibility. 
Catalytic response toward NaNO2 was detected with polyanionic poly(vinyl sulfonate)-
Hb (PVS-Hb) layer-by-layer modified PG electrodes. Percentage of electroactive Hb 
was 46% and ks around 50 s
-1 
(Wang and Hu, 2001; Shen and Hu, 2005).  
 
Another example of an electrochemical biosensor is based on fructosyl – amine oxidase. 
HbA1c was detected by specific antibodies and then H2O2 was produced as a result of 
fructosyl – valine oxidization, evaluated amperometrically. The sensor (Pt, Ag/AgCl) 
was protected against non-specific adsorption of protein by cellulose membrane and 
thus avoided its passivation (Stollner et al., 2002). 
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Chapter 3: MIP technology  
Molecular imprinting is a generic technology for the introduction of recognition 
properties into synthetic polymers (Piletsky and Turner, 2006). The process includes 
formation of a complex between the template molecule and a functional monomer. This 
structure in molecularly imprinted polymers (MIPs) is “stiffened” by co-polymerisation 
with cross-linker. Eventually, the printed molecule is extracted in a washing step, while 
binding sites specific to the template are left in the polymeric network (Piletsky and 
Turner, 2002). 
 
 
Figure 11. Schematic process of molecular imprinting technology  
 
Functional and cross-linking monomers having vinyl and acrylic group are commonly 
used in the technology. However other organic polymer and silica are also exploited 
(Haupt and Mosbach, 2000).  
 
Novel technology for HbA1c determination may include a recognition layer of 
molecularly imprinted polymer integrated with an electrochemical transducer. 
Biomimetic sensors, which employ artificially created materials, would be very 
desirable in the sensor area. Also the application of chemical compounds with high 
affinity to the analyte can be useful. For instance, Bossi et al. (2004) achieved some 
positive results in separation of haemoglobin by capillary electrophoresis, but further 
improvement, for example, the extending detection range remains to be done. APBA 
was polymerised in aqueous environment onto silica capillaries. Such materials could be 
useful in devices such as microchips (Bossi et al., 2004).  
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3.1.1 Different approaches in MIP preparation. 
 
MIP can be made as a self-assembly or pre-organised system (Figure 12.). Each of these 
strategies has its advantages. 
 
 
Figure 12. Different approaches in MIP preparation. 
 
Monomers covalently bound with a template create polymers with higher stability and 
homogenous population of binding sites. On the other hand, non-covalent interactions 
are more similar to these occurring in natural systems in which most interactions are 
non-covalent and could be used for imprinting of proteins with a variety of segments 
and folding motives. Therefore MIP for protein recognition could be more efficient 
employing weak multipoint interactions instead of a few strong bonds. The non-
covalent interactions seem to be more compatible with biological materials (Haupt and 
Mosbach, 2000; Bossi et al., 2001). These two strategies were combined in Hb 
imprinting to introduce useful features from both of them (Shiomi et al. 2005). 
Template was covalently attached to the functional monomer, but an analyte was 
rebound by a noncovalent association. This approach can be used to hydrolyze ester, 
amide, imine bond and utilise rebinding through electrostatic interaction between for 
example respective amine and carboxylic acid. However, problems may appear during 
template removal. Binding capacity and selectivity may be lowered due to high stability 
of the monomer-template complex. Incorrect positioning of functional group for optimal 
non-covalent recognition may also have a significant impact (Klein et al., 1999; Shiomi 
et al. 2005). 
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Procedures for MIP preparation encompass a bulk polymerisation (Piletsky and Turner, 
2002), surface grafting (Bossi et al., 2001) or electropolymerisation (Rick and Chou, 
2006). Surface grafting and electropolymerisation are believed to be more suitable for 
protein imprinting. They can overcome problems, such as destruction of affinity sites, 
restricted mobility and poor reversibility while ensuring efficiency in the binding 
process. Surface support can play a stabilisation role and help to achieve correct 
orientation of functional sites (Bossi et al., 2001; Wei et al., 2006). The affinity of 
conventional MIP preparation was 100 times smaller than the affinity of grafted MIP on 
the polystyrene surface (Bossi et al., 2001). These procedures lead to formation of two 
or three dimensional structures with specific cavities for small and more complex 
molecules. 
3.1.2 Two and three-dimensional MIPs 
Grafted layers can be formed by aminophenyl boronic acid (APBA) on the electrode 
surface in the presence of haemoglobin. The holes remaining after the template 
extraction have been reported to be complementary in size to the template molecule 
(Bossi et al., 2001).  
 
Phenyl boronic acid (PBA) has been used in many studies because of the boron group, 
which forms a diol recognition element acting as an antibody – mimicking compound. 
A covalent bond is formed between aminophenyl boronic acid and cis-diol group of 
glucose attached to haemoglobin under alkaline conditions (Frantzen et al. 1995). 
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Figure 13. Boronate-diol ester formulation (Pribyl and Skladal, 2006). 
 
An experiment using aniline and APBA for a protein imprinting showed possibility of 
electrostatic interaction between boronic acid and secondary amino and hydroxyl groups 
in the template.  However aniline has positive charges which might react non-
specifically with negative residues of the protein. As a result, discrimination between 
specific and non-specific binding can be difficult to achieve. In this respect poly-APBA 
which holds an equal number of positive and negative charges is better suited for 
protein imprinting (Piletsky, 2001).  
 
MIP formation for detection of glycated haemoglobin (HbA1c) was successfully 
performed by Bossi et al. (2001). The formed MIPs were able to distinguish between 
HbA0 and HbA1c (Table 2).  
 
Table 2. Analysis of haemoglobin binding to imprinted polymers prepared from APBA 
(Bossi et al., 2001). 
MIP \ Analyte 
HbA1c HbA0 
KdS (nM) 
HbA1c 65 +/- 2 162 +/- 9 
HbA0 188 +/- 10 58 +/- 2 
 
A surface grafting approach was utilized in this research. Polymer was formed around 
the template on a solid surface of microplates (Bossi et al., 2001). As a result, the 
polymer did not have a high level of cross-linking which probably helped to recognise 
flexible protein structure (Piletsky et al. 2006). Haemoglobin properties, such as shape 
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and difference in isoelectric points were explored in the detection process (Bossi et al., 
2001). 
 
APBA was also successfully used to detect another protein. This time two layers of 
APBA were deposited on the polypyrrole substrate. The outer layer was polymerised in 
the presence of lysozyme or cytochrome c. An imprinting procedure was successfully 
employed to detect these proteins. Sensor showed characteristic two-phase response 
after binding with lysozyme. The first step showed change of concentration, probably 
due to specific binding sites and the second phase showed smaller change because of a 
non-specific binding. However, the procedure was not reproduced for other proteins, 
such as RNAseA and myoglobin (Rick and Chou, 2006). 
 
Table 3. Percentage current decreases with the increasing concentration of protein (Rick 
and Chou, 2006) 
Lysozyme 
Concentration (ppm) 
Observed electrode % current reduction 
Templated Control 
1 30.3 4.5 
2 48.8 15.9 
4.8 62.0 29.8 
9.4 68.3 45.8 
 
Electrochemical measurements were performed on screen printed platinum as a working 
electrode at the potential -100 mV vs Ag/AgCl reference electrode. The passage of 
current decreased more rapidly when proteins were bound to the imprint than to control 
electrode. This was probably caused as a result of the specific binding due to shape 
complementarity of specific binding sites. The thickness of recognition layer seems to 
be very important. It can influence binding specificity of template entrapment (Rick and 
Chou, 2006). 
 
In another example Hb was imprinted on a silica surface and showed selective 
absorption. It was possible to distinguish haemoglobin from myoglobin despite the 
smaller size of myoglobin (17.5 kDa) and approximately the same pI (Shiomi et al. 
2005). 
 
 31 
 
Furthermore, the epitope approach, which exploits a short terminal protein as a template 
shows great promise. The produced recognition site may enable specific determination 
of unstable proteins, which is problematic using traditional imprinted polymers made 
using whole protein template (Rachov and Minoura, 2001).  
3.1.3 MIC-Molecular imprinted catalyst 
It is also possible to create an artificial enzyme by using MIP technology. An attempt to 
create an artificial fructosylamine dehydrogenase was made by Sode et al. (2003). 
Methyl valine, an analog of fructosyl valine (Fru-val), was used as a template molecule. 
Allylamine was used as a functional monomer to increase selectivity toward Fru-val. It 
was possible to distinguish Fru-val from fructosyl-e-lysine. This was comparable with 
another piece of work (Yamazaki et al., 2003) where fru-val was used as a template. 
Functional monomer, 4-vinylboronate, and cross-linker, EDMA-ethylene glycol 
dimethacrylate were used. The authors produced a co-polymer, polyvinylimidazole, 
which functioned as a catalyst of the oxidative hydrolytic reaction of fructosylamine 
compounds in the presence of electron acceptor and polyvinylphenylboronate. m-PMS 
(1-methoxyl-5-methylphenazinium methylsulfate) was used as an electron acceptor. To 
be used in blood this approach however will require pre-treatment with a protease to 
release fru-val residue from protein molecule (Sode et al., 2003). 
3.1.4 Parameters influencing MIP performance 
There are many parameters affecting MIPs structure and their molecular recognition 
properties as shown in Table 4. These parameters often interplay together, thus it is 
necessary to understand them to create the most suitable balance among them. For 
example, both higher concentration of initiator and increased time of polymerisation are 
able to decrease polymer swelling (Mijangos et al., 2006). It was assumed that MIP 
should be synthesised using low concentrations of initiator and low temperatures, but 
time of this process should be increased. Temperature should also be optimised along 
with pressure and polymer swelling. It is necessary to optimise incubation conditions 
during analyte detection as well (Piletsky et al., 2004; Romanaviciene and 
Romanavicious, 2004). 
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Table 4. Influence of parameters on efficiency of molecular imprinting. 
Polymerisation 
parameters 
Influence  References 
Type and 
concentration of 
monomers, cross-
linker, solvent 
bonds generation  
polymer affinity and specificity 
polymer structure stabilisation 
(Piletsky et al., 
2001; Piletsky et al., 
2002 ; 
Romanaviciene, 
Romanavicious 
2004; Karim et al., 
2005) 
Template : functional 
monomer ratio 
Complex formation and re-binding of a 
template 
(Lin et al., 2007) 
Initiator higher concentration –higher rigidity, 
increased temperature, larger surface 
area,  
lower amount – decreased temperature, 
superior recognition abilities 
(Mijangos et al., 
2006) 
Solvent 
 
 
Organic solvent is not suitable media 
for protein imprinting. Type of solvent 
affects volume and diameters of pores 
and swelling process. Polar solvent 
improves biocompatibility but is 
responsible for destabilisation of 
electrostatic interaction between 
functional monomer and template  
(Haupt and 
Mosbach, 2000 ; 
Mijangos et al., 
2006; Wei et al., 
2006; Piletsky et al., 
2002; Yilmaz et al. 
2000) 
Template molecule  Size, complexity, functional group, 
charge (kind and distribution) affects 
quality of created sites and their 
accessibility  
(Romanaviciene and 
Romanavicious 
2004), (Piletsky et 
al., 2001) 
Ionic strength Influences polymer-ligand binding (Karlsson et al., 
2001) 
Time Longer polymerisation time increases 
polymer rigidity and specificity; 
possible slow binding kinetics  
(Piletsky et al., 2002 
; Mijangos et al., 
2006) 
Temperature 
 
Lower temperature increased strength 
of polar interactions and produces better 
quality of the imprinting cavities 
(Piletsky et al., 2002 
; Mijangos et al., 
2006) 
pH Extreme pH value might cause protein 
denaturation; has influence on affinity 
depending on polymer/template 
properties 
(Romanaviciene and 
Romanavicious 
2004) 
Pressure Plays indirect role in morphology and 
performance of polymers, influence on 
the boiling temperature of the solvent 
(Piletsky et al., 
2004) 
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3.1.5 Design of molecularly imprinted polymers 
From the theoretical point of view, MIPs can be generated for any substance even if 
there is no corresponding biological receptor. So far imprinted polymers were 
developed successfully for inorganic ions, nucleic acids, pharmaceuticals, sugars, 
proteins and cells (Piletsky et al., 2001). This technology has significant advantages in 
comparison to other methods where biological material is applied. Its application could 
improve stability, reduce cost and facilitate preparation (Piletsky et al., 2006). 
 
Improvement in MIP preparation can be achieved by application of chemometrics 
(statistical analysis) (Mijanogos et al., 2006), computational design and combinatorial 
chemistry. Simulation experiments facilitate understanding of molecular mechanisms 
governing molecular imprinting processes (Wei et al., 2006). Molecular modelling can 
enable selecting the most suitable parameters, such as functional monomers, cross-
linkers and solvents and thus provide very stable complex in the pre-polymerisation 
mixture (Piletsky et al., 2002; Karim et al., 2005). However, the accuracy of these 
results has to be confirmed by experimental analysis and the validity of the model 
system should be established (Wei et al., 2006). 
 
A thermodynamic model for the MIP design was suggested by Nicholls. The binding 
site distribution and the binding equilibrium were studied (Nicholls, 1998). Molecular 
modelling has been applied for optimisation of polymer composition using protocol 
developed in Cranfield University (Nicholls et al., 2005). The studies showed that 
affinity of computationally designed MIPs is similar to those of polyclonal antibodies. 
Kd 0.3 ± 0.08 nM (computational MIP) and 0.5 ± 0.07 nM (polyclonal antibodies) and 
estimated sensitivities are also within similar range (0.1-100 and 0.05-10 µg/L 
correspondingly) (Piletsky and Turner, 2002). 
 
Until now molecular imprinting has been usually employed for small molecules. 
Therefore it is still a challenge to obtain a MIP for protein detection, especially where 
the protein is characterised by a high molecular weight, such as haemoglobin (Karim et 
al., 2005; Piletsky et al., 2006). The problems with protein imprinting are mainly 
caused by an unstable three – dimensional structure, possible rearrangement processes 
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and a poor solubility of the template in organic solvents (Bossi et al. 2006). Also use of 
epitope approach for the recognition of two similar proteins, such as HbA1c and HbA0 
may be problematic.  
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Chapter 4: Device configuration 
It would be desirable to configure a device that integrates laboratory functions on a 
single small chip, capable of handling extremely small fluid volumes. Miniaturising a 
chemical analysis system is very important and microsystem technology to deal with 
“micro” amounts of fluids has to be developed. This approach exploits areas such as 
micro-electro-mechanic systems (MEMS), lab-on-a-chip technology and micro Total 
Analysis Systems (μTAS) (Noda et al., 2006). Blood analysis has been performed 
reasonably often using such devices (Son et al., 2006; Noda et al., 2006 and Tanaka et 
al., 2006).  
4.1 MIP and other recognition materials as a chromatographic 
medium 
One approach may encompass separation of HbA1c on a MIP - chromatographic 
medium combined with electrochemical detection. The chromatographic matrix could 
increase the number of specific recognition sites and enable efficient detection.  
 
Presently, an ionic exchange matrix and boronic affinity materials are used for 
separation of glycated haemoglobin. An attempt to measure HbA1c using a chip based 
on a miniaturised flow immunoassay systems was performed by Tanaka et al. (2006). 
Lab-on-a-chip technology has been developed in which boronate-affinity 
chromatography was combined with electrochemical detection. The process is showed 
in Figure 14. Antibodies were conjugated with ferrocene monocarboxylic acid, which is 
good electrochemical label. Separation of HbA1c was performed on a column packed 
with agarose beads consisting of m-APBA. Detection took place in an electrochemical 
cell equipped with a glassy carbon electrode (WE), platinum (CE) and Ag/AgCl (RE) 
(Tanaka et al., 2006). Tanaka et al. (2009) also developed a similar electrochemical 
system with a cation exchange resin for HbA1c separation. HbA1c level was 
determined in a range from 4 to 12.6 %, spectrophotometrically and electrochemically. 
Presented results, however, concern mainly spectrophotometric detection of HbA1c. 
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Moreover the RSD% of electrochemical detection of HbA1c up to 19.1% may suggest 
that the system did not work efficiently (Tanaka et al. 2009).  
 
 
Figure 14. Schematic diagram of an on-chip electrochemical flow immunoassay system 
(Tanaka et al., 2006). 
 
Another approach was introduced by a Son and co-authors (Son et al., 2006). They 
proposed a disposable chip for measurement of HbA1c (%), which involved use of 
APBA as a separation material but without biological sensing elements. In the 
description given, the blood suspension was transferred by a micropump which 
produced oxygen by decomposing hydrogen peroxide with a microheater. In the second 
step, blood was separated into plasma and red blood cells. The latter was ruptured in the 
lysis chamber giving a mixture of haemoglobin which flowed into two channels. 
 
 
 
Figure 15. Schematic of the % HbA1c measurement process (modified from Son et al., 
2006) 
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One of the channels led straight to the electrode and gave the signal 1 reflecting the 
whole content of haemoglobin. The second had a binding chamber, which consisted of 
m-APBA agarose beads. Therefore the HbA1c was captured and the signal 2 reflected a 
content of non-glycated haemoglobin. The electrodes were IDA-shaped (interdigitated 
array electrodes) and had a high-aspect-ratio (elongation) to magnify contact area and 
improve sensitivity. Electrodes consisted of nickel and gold (Son et al., 2005; Son et al., 
2006). There were however essential details missing in this paper and it would be 
difficult to construct a working system based on the information provided.  The paper 
also lacks clear evidence that the system worked as an effective assay.  
4.2 MIP integration with transducer – biomimetic sensor 
Molecularly imprinted polymer technology combined with an electrochemical reader 
and microfluidics would be very desirable in medical diagnostics. Biomimetic sensor 
may be a basis for construction of a miniaturized device for HbA1c determination. The 
device configuration may be similar to the one presented above, but the separation 
process would be replaced with a sensing of an analyte using MIP-electrodes.  
 
A very important issue in the development of a biomimetic sensor is the integration of a 
sensitive transducer with the recognition system (MIP). There should be a close contact 
between them. A device should be able to detect the binding process and transform it 
into a readable signal. Introduction of automated production process would be an 
additional advantage. Polymer can be synthesised directly on the transducer or as a thin 
membrane and then transferred onto the transducer’s surface (Haupt and Mosbach, 
2000; Piletsky and Turner, 2002).  
 
It was reported that MIP particles could coat the working carbon electrode as a thin 
layer (Kroger et al., 1999). A stable thin membrane could also be photo-deposited on 
the sensor surface or used directly in conductometric sensors (Piletsky and Turner, 
2002). In the case of an electrochemical transducer, molecular imprinting by 
electropolymerisation appears convenient. Its application allows for a precise placing of 
MIP layer and coating of the electrode with homogenous film (Kriz et al., 1995; Rick 
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and Chou, 2006). The polymer thickness and deposition density are controlled by the 
polymerisation conditions, such as applied voltage and deposition time. By such means, 
polyaniline and polypyrrole layers were prepared (Vinokurov, 1992). Panasyuk et al. 
(1999) successfully prepared electropolymerised o-phenol for phenylalanine detection. 
Malitesta and co-authors reported an application of the same procedure for o-
phenylenediamine, where glucose was imprinted on a QCM transducer (Malitesta et al., 
1999). Another example is an amperometric protein sensor made by electrodeposition of 
a monomer, APBA, on a gold or platinum screen-printed support or electrodeposition of 
polypyrrole and p-APBA (Rick and Chou, 2006).   
 
Considering whether the sensor should be disposable or not, its stability and 
regeneration issue have to be taken into account. Problems may result from a partial 
destruction of the binding sites in the polymer matrix (Bossi et al., 2001; 
Ramanaviciene and Ramanavicious, 2004). Furthermore, the signal may decrease 
because of mediator leaching (Scheller et al., 2005), and some residual species may be 
left after the previous measurement (Brett et al., 1999). These and other considerations 
restrict the re-use of sensors and favour disposable device construction. It is also less 
complicated and a relatively cheap procedure to use MIP technology in combination 
with electrochemistry to create a disposable device (Hart et al., 2003).  
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Chapter 5: Conclusions 
There are no reports of HbA1c sensor incorporating MIP technology and 
electrochemical detection so far. The development of such a device would be highly 
innovative. This review has illustrated some different possibilities for total Hb and 
HbA1c determination including electrochemistry and MIP technology. Despite 
numerous studies about direct electron transfer and catalytic activity of Hb, the practical 
application of this approach is still limited. However, some ideas from this area that 
may help to improve Hb immobilisation or protect the molecule, could be explored in 
mediated sensors.  It should be noted that the catalytic activity of Hb may be reduced by 
the organic solvent that is used for MIP preparation. Phenyl boronic acid derivatives 
(PBA) have been many times recognised as having a good affinity towards total 
glycated haemoglobin (GHb).  It seems to be a suitable molecule for further research in 
the sensor area. MIP technology or a non-imprinting approach together with various 
transducers may be used to construct a sensor for HbA1c determination.  
 
Some promising results presented in this review show potential for using molecular 
imprinting combined with mediators in electrochemical detection of glycated 
haemoglobin (HbA1c). It is clear however that the imprinting of protein is difficult. 
New protocols both for electrochemical detection, MIP preparation and their integration 
into a device may be required. 
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SECTION II: EXPERIMENTAL 
Chapter 6: Electrochemical behaviour of mediators on commercial 
electrodes 
6.1 Materials and methods 
6.1.1 Reagents 
Potassium ferricyanide (CAS No: 13746-66-2), potassium ferrocyanide (CAS No: 
14459-95-1), MB (Methylene Blue, CAS No: 7220-79-3), ABTS (2,2′-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid) diammonium salt, CAS No: 30931-67-0), 
FcCOOH (ferrocenecarboxylic acid, CAS No: 1271-42-7), HQ (hydroquinone with 
CAS No: 123-31-9), DCPIP (dichlorophenol indophenol, CAS No: 620-45-1), sodium 
monobasic phosphate (CAS No: 7558-80-7), sodium dibasic phosphate (CAS No: 7558-
79-4), potassium chloride (CAS No: 7447-40-7), sodium chloride (CAS No: 7647-14-5), 
sodium hydroxide (CAS No: 1310-73-2),  were purchased from Sigma-Aldrich (Dorset, 
UK). Alumina 0.3µm particle and alumina polishing pads (tan, velvet) were purchased 
from BASi Electrochemistry Instruments (Warwickshire, UK).  Chemicals were used as 
received. 
6.1.2 Apparatus 
All electrochemical experiments were performed with a Uniscan potentiostat - 
galvanostat instrument PG580 with UiEChem software (Buxton, UK). The Uniscan 
instrument was used with a beaker or an electrochemical cell which consisted of Screen 
Printed Electrodes (SPE) or a three electrode cell, respectively.  
 
The three electrode cell consisted of a gold (A=2.01 mm
2
) as a working electrode and 
platinum (A=2.01 mm
2
) as a counter electrode. They were purchased from BASi 
Electrochemistry Instruments (Warwickshire, UK). Calomel electrode was used as a 
reference electrode and was purchased from Sigma-Aldrich (Dorset, UK). The gold and 
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platinum electrodes were cleaned after each measurement. Electrodes were cleaned 
firstly with alumina 0.3 µm particle on a polishing pad and thoroughly rinsed with 
distilled water (dH20). Following this the electrode was polished on a polishing pad 
soaked with dH20 and thoroughly rinsed with dH20. 
 
Screen Printed Electrodes (SPE-D) and Screen Printed Electrodes - Carbon Nanotubes 
(SPE CNT-D) were purchased from DropSens Ltd. (Oviedo, Spain). Electrodes were 
fabricated on ceramic substrate: L33 x W10 x H0.5 mm, electric contacts and a 
reference electrode were made from silver, a working electrode (A=12.56 mm
2
) and a 
counter electrode was made with carbon. Other type of SPEs (SPE-S) was provided by 
Microarray Ltd. They consisted of two carbon working electrodes (A=22.53 mm
2
 each), 
counter electrode was made with a carbon and reference electrode was made of the 
Ag/AgCl paste. Conductive paths were masked with dielectric coat. Additional type of 
SPEs (SPE-G) was also kindly supplied by GEM Ltd. (Pontypool, UK). They were 
fabricated on a polystyrene substrate with a carbon working electrode (A=3.14 mm
2
), a 
carbon counter electrode and Ag/AgCl as a reference electrode. Conductive paths were 
covered with a dielectric layer. Pelikan Technologies Inc. provided SPE (SPE-P) which 
consisted of a conductive layer, an insulating layer, Ag/AgCl as a reference electrode, 
Ag/AgCl as a counter electrode, a carbon working electrode (A=0.25 mm
2
) and a spacer 
layer. SPEs were also printed in Cranfield (SPE-C) on a polyester sheets, and they 
consisted of carbon as a working electrode (A=19.63 mm
2
), carbon as a counter 
electrode and Ag/AgCl as a reference electrode. Conductive paths were covered with an 
insulating ink. SPEs were used without any pre-conditioning.  
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Figure 16. SPE electrodes, 1) SPE-G, 2) SPE-S, 3) SPE-C, 4) SPE-P, 5) SPE-D,  
6) SPE CNT-D 
 
pH meter, Hanna Instruments 8519 was purchased from Hanna Instruments Inc. 
(Woonsocket, USA) and was used for preparation of buffer solutions. 
6.1.3 Electrochemical analysis 
Cyclic voltammetry and linear voltammetry were used for the qualitative 
characterisation of electrodes. Linear voltammetry was run from positive toward 
negative potentials. The cyclic voltammetry was started from negative potentials, except 
studies with MB and DCPIP. All solutions used for electrochemical analysis were 
prepared daily. Mediator was prepared in a buffer deoxygenated by purging with 
nitrogen and was kept in 4
o
C during measurements. Measured samples contained 0 or 
0.5 mM mediator. Phosphate buffer (40 mM) consisted of sodium monobasic 
phosphate, sodium dibasic phosphate and a supportive electrolyte potassium chloride 
(100 mM) at pH 7.0.  
 
Measurements were performed at room temperature (22
o
C). Experiments were 
performed using SPE without modification. Electrodes were immersed in a vertical 
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position in a 10 mL beaker. Experiments were also performed in a 10 mL 
electrochemical cell, which consisted of a gold working electrode, a platinum counter 
electrode and a calomel reference electrode. The electrode configuration described 
above was employed in all experiments. CV was performed under unstirred conditions. 
All measurements were run in triplicate. Data were transferred to Microsoft Office 
Excel and average values calculated. 
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6.2 Results and Discussion 
6.2.1 Electrochemical behaviour of chosen mediators using an 
electrochemical cell  
Preliminary studies were performed in a classical electrochemical cell with bulk 
electrodes. They might have had better repeatability and characteristic than SPEs which 
is crucial in the biosensor field. Redox behaviour of mediators is shown on cyclic 
voltammograms (Figures 17-22). Three cycles were performed for each mediator at a 
scan rate 50 mV/s. Table 5 shows a characterisation of mediators using the second cycle 
and also a first cycle for DCPIP. 
 
Table 5. Mediator characteristic performed in the electrochemical cell (second cycle). 
  Epa Epc ∆Ep ipa ipc 
Mediator mV µA 
FcCOOH 315 245 70 1.62 -1.4 
HQ 305 -105 410 3.06 -2.45 
Ferrocyanide 225 150 75 1.67 -1.58 
MB -215 -255 40 1.06 -1.17 
ABTS 505 405 100 1.17 -0.814 
DCPIP  
first cycle 
65 -270 335 1.15 -1.24 
DCPIP  
second cycle 
510 -270 780 1.39 -1.24 
 
CVs of DCPIP exhibited significantly different positions of reduction and oxidation 
peaks to the other redox compounds. Increased peak separation was observed with each 
subsequent cycle (Figure 20). Other mediators did not show significantly different peaks 
positions in subsequent cycles. Mediators showed a higher oxidation peak in a first 
cycle, except methylene blue which showed a higher oxidation and reduction peak in 
the subsequent cycles (Figure 18). Hydroquinone showed a useful reduction potential. 
The reduction peak was slightly shifted toward positive potential with each cycle, Epc 
for the first, second and third cycle was -110 mV, -100 mV and -90 mV, respectively 
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(Figure 21). This mediator showed the biggest peak separation, 410 mV and also the 
highest current response with values of anodic and cathodic current estimated to be 3.06 
and -2.45 µA, respectively (Table 4). Separation of redox peaks, larger than 59 mV for 
mediators, such as potassium ferrocyanide, ferrocenecarboxylic acid, and 29.5 mV for 
mediators, such as hydroquinone, methylene blue, ABTS and DCPIP indicate a quasi-
reversible process. However, relatively good separation of peaks was achieved for 
potassium ferrocyanide, ferrocenecarboxylic acid, methylene blue and ABTS. 
 
 
Figure 17. Cyclic voltammetry of FcCOOH (0.5 mM) in PB buffer at pH 7.0. The 
electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rate 50 mV/s. 
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Figure 18. Cyclic voltammetry of MB (0.5 mM) in PB buffer at pH 7.0. The 
electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rate 50 mV/s. 
 
 
Figure 19. Cyclic voltammetry of ABTS (0.5 mM) in PB buffer at pH 7.0. The 
electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rate 50 mV/s. 
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Figure 20. Cyclic voltammetry of DCPIP (0.5 mM) in PB buffer at pH 7.0. The 
electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rate 50 mV/s. 
 
 
Figure 21. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0. The 
electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rate 50 mV/s. 
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Figure 22. Cyclic voltammetry of potassium ferrocyanide (0.5 mM) in PB buffer at pH 
7.0. The electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rate 50 mV/s. 
 
6.2.2 Comparison of Screen Printed Electrodes 
Screen printed carbon electrodes were tested as electrodes of choice since they are 
relatively inexpensive, characterised by a wide potential window and a low background 
current (Wang, 2006). Additionally it is more convenient to conduct research on 
disposable electrodes and avoid a time-consuming cleaning procedure. Studies can be 
also performed in a small volume of reaction mixture which is essential in case of work 
with expensive reagents.  
 
Linear voltammetry and cyclic voltammetry were used to characterise screen printed 
electrodes (SPEs). The SPE-P showed the broadest potential window. Current resulting 
from hydrogen and oxygen evolution should not be recorded. The SPE-D, SPE-CNT-D 
and SPE-G showed narrower cathodic potential. Cathodic current started to increase at a 
potential above -600 mV for SPE-D, -400 mV for SPE-CNT-D and -200 mV for SPE-G 
electrodes. Electrochemical cell showed noise at a potential about +500 mV and 
significant increase in cathodic current at a potential around -800 mV (Figure 23). The 
properties of working electrode surface might have had an influence on presented 
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results. Cyclic voltammetry was used to characterise commercial SPEs using potassium 
ferricyanide and HQ at a scan rate 50 mV/s (Figures 24-35). Tables 6-7 show SPEs 
characteristics measured for the second cycle.  
 
Table 6. Characterisation of SPEs with potassium ferricyanide. 
 Potassium ferricyanide 
SPE Epa Epc ΔEp ipa ipc ja jc 
 mV µA µA/cm
2
 
Pelikan 405 -235 640 0.0602 -0.108 24.08 -43.20 
DropSens 190 55 135 5.85 -5.77 46.57 -45.94 
DropSens CNT 160 70 90 4.91 -5.24 39.09 -41.72 
GEM 175 95 80 1.75 -1.69 55.73 -53.82 
SPE-S 515 -260 775 9.02 -3.72 40.04 -16.51 
SPE-C 455 -140 595 8.22 -5.56 41.89 -28.33 
 
Table 7. Characterisation of SPEs with hydroquinone. 
 Hydroquinone 
SPE Epa Epc ΔEp ipa ipc ja jc 
 mV µA µA/cm
2
 
Pelikan 445 -240 685 0.264 -0.109 105.60 -43.60 
DropSens 160 -110 270 17.3 -18.3 137.74 -145.70 
DropSens CNT 100 -90 190 6.04 -6.54 48.09 -52.07 
GEM 165 -120 285 2.87 -2.75 91.40 -87.58 
SPE-S 410 -230 640 25.5 -21 113.20 -93.22 
SPE-C 520 -370 890 16.7 -13.1 85.10 -66.75 
 
CVs for potassium ferricyanide and HQ performed on SPE-D and SPE-G electrodes 
showed the most reversible behaviour in comparison to the other SPEs (Figures 28-31). 
Peak position and separation for potassium ferricyanide was similar to the gold 
electrode used with the electrochemical cell. The CV of HQ even showed decreased 
peak to peak separation in comparison to the electrochemical cell. DropSens CNT-D 
showed the smallest peak separation for hydroquinone (190 mV). However the anodic 
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and cathodic peak currents were not the same. A significant difference was observed on 
the SPE CNT-D for potassium ferricyanide with each cycle and the same effect was 
visible for HQ (first cycle) on the same electrodes (Figures 30, 31). Other screen printed 
electrodes showed an increased peak separation, thus slower electron transfer. It can be 
described as a quasi-reversible process (Pletcher, 1991). Probably the results were 
caused by different carbon ink used for the preparation of the SPEs. Research performed 
by Wang et al. also showed differences in peak separation of potassium ferrocyanide on 
different types of carbon. Similar tendency was obtained for catechol and 
acetaminophen (Wang et al., 1998). 
 
The highest anodic and cathodic current density for potassium ferricyanide was 
obtained for SPE-G electrodes, 55.73 and -53.82 µA/cm
2
, respectively. However, SPE-
G electrodes showed also very irregular CVs without clear reduction peak (Figure 34). 
The highest current density for hydroquinone was obtained on SPE-D electrodes, where 
the anodic current was calculated to be 137.74 µA/cm
2
 and the cathodic current -145.70 
µA/cm
2
. The cyclic voltammogram of hydroquinone showed an increase of the anodic 
and cathodic current on the SPE CNT-D with each subsequent cycle (Figures 30, 31). 
The CV of potassium ferricyanide only showed an increase in anodic current with the 
each subsequent cycle (Figure 31). The summarized data are presented in Table 8.  
 
Table 8. Peaks of anodic and cathodic current on SPE CNT-D for HQ and potassium 
ferricyanide 
 HQ Potassium ferricyanide 
cycle 
number 
ipa ipc ipa ipc 
i(µA) 
1 5.6 -3.57 3.48 -3.38 
2 6.04 -6.54 4.91 -5.21 
3 7.81 -8.04 5.01 -4.05 
 
Preparation of SPEs, namely composition of material and fabrication condition might 
have had a significant influence on a rate of electron transfer and behaviour of redox 
system at a working electrode, such as background and faradaic current, peaks position 
and their separation. Wang et al. (1996) demonstrated that curing temperature has 
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positive effect on electrode performances due to removal of organic solvents. They also 
proved that electrochemical pre-treatment, anodization and cathodization could partially 
improve electrodes characteristic. Functional groups (quinone and carboxyl group), 
which are introduced at a high positive polarization potential, facilitate electron transfer 
(Wang et al., 1996). 
 
 
Figure 23 Scan from positive toward negative potential on different electrodes in PB pH 7.0 
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Figure 24. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0 on SPE-C 
electrodes. Scan rate 50 mV/s. 
 
 
Figure 25. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-C electrodes. Scan rate 50 mV/s. 
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Figure 26. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0 on SPE-S 
electrodes. Scan rate 50 mV/s. 
 
 
Figure 27. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-S electrodes. Scan rate 50 mV/s. 
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Figure 28. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0 on SPE-D 
electrodes. Scan rate 50 mV/s. 
 
 
Figure 29. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-D electrodes. Scan rate 50 mV/s.  
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Figure 30. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0 on SPE CNT-D 
electrodes. Scan rate 50 mV/s. 
 
 
Figure 31. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE CNT-D electrodes. Scan rate 50 mV/s. 
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Figure 32. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0 on SPE-G 
electrodes. Scan rate 50 mV/s. 
 
 
Figure 33. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-G electrodes. Scan rate 50 mV/s. 
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Figure 34. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-G electrodes. Scan rate 50 mV/s. 
 
 
Figure 35. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.0 on SPE-P 
electrodes. Scan rate 50 mV/s. 
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Figure 36. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-P electrodes. Scan rate 50 mV/s. 
 
6.2.3 Influence of scan rate on performance of SPE-D electrodes and 
electrochemical cell 
SPE-D electrodes were compared to the electrochemical cell. Cyclic voltammetry was 
used to compare the SPE-D with the electrochemical cell using the potassium 
ferricyanide at different scan rate (Figures 37-40).  
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Table 9. Electrochemical cell with the potassium ferricyanide at different scan rates. 
Scan 
rate 
Electrochemical cell 
V V
1/2
 ipa ipc Epa Epc ∆Ep ja jc 
V/s µA mV µA/cm
2
 
0.005 0.070711 0.59 -0.295 225 155 70 29.36 -14.68 
0.02 0.141421 1.1 -0.784 225 155 70 54.74 -39.01 
0.05 0.223607 1.67 -1.32 225 150 75 83.10 -65.68 
0.08 0.282843 2.15 -1.77 225 150 75 106.99 -88.08 
0.1 0.316228 2.35 -1.98 230 150 80 116.94 -98.53 
0.15 0.387298 2.86 -2.44 230 140 90 142.32 -121.42 
 
Table 10. SPE DropSens with the potassium ferricyanide at different scan rates. 
Scan rate SPE DropSens 
V V
1/2
 ipa ipc Epa Epc ∆Ep ja jc 
V/s µA mV µA/cm
2
 
0.005 0.070711 0.93 -1.55 180 75 105 7.41 -12.34 
0.02 0.141421 3.8 -4.23 185 70 115 30.25 -33.68 
0.03 0.173205 4.04 -4.79 185 60 125 32.17 -38.14 
0.05 0.223607 4.85 -5.77 190 50 140 38.61 -45.94 
0.08 0.282843 7.02 -6.91 205 50 155 55.89 -55.02 
0.1 0.316228 7.99 -7.47 210 50 160 63.61 -59.47 
 
A linear dependence ip vs square root of scan rate was obtained with the electrochemical 
cell and also SPE-D electrodes. Electrochemical cell showed linearity described by the 
equation y (ipa) =7.19x+0.081 with R
2
=0.9995 and y (ipc) =-6.81+0.184 with R
2
=0.9995. 
The SPEs displayed linearity according to the equation y (ipa) =25.02x-0.152 with 
R
2
=0.9567 and y (ipc) =-18.76x-1.567 with R
2
=0.9996. Linear dependence of peak 
current from the square root of the scan rate indicates reversible reaction (Wang, 2006). 
Peak separation was different at applied scan rates for both examples, but for the 
electrochemical cell, this was not significant (Tables 9-10). Higher anodic and cathodic 
current density was obtained with the electrochemical cell. 
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Figure 37. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0. The electrochemical cell: Au-WE, Pt-CE, calomel-RE. Scan rates from 5 to 150 
mV/s. 
 
 
Figure 38. Plots of anodic (ipa) and cathodic (ipc) peaks current of potassium ferricyanide 
vs. v
1/2 
from CVs of Figure 37. 
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Figure 39. Cyclic voltammetry of potassium ferricyanide (0.5 mM) in PB buffer at pH 
7.0 on SPE-D electrodes. Different scan rate from 5 to 150 mV/s. 
 
 
Figure 40. Plots of anodic (ipa) and cathodic (ipc) peaks current of potassium ferricyanide 
vs. v
1/2 
from CVs of Figure 39. 
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6.3 Conclusions 
The electrochemical performance of several disposable screen printed carbon electrodes 
and the classical electrochemical cell with bulk electrodes were compared. SPE-D 
electrodes were chosen for further research since they showed the best characteristics. 
SPEs would allow conducting research with a small volume of samples, which is 
required to study an expensive analyte such as glycated haemoglobin (HbA1c).   
 
  
 63 
 
Chapter 7: Peroxidase system optimisation 
Initial experiments were focussed on developing a model system for investigation of 
electrochemical properties of haemoglobin. The aim of this chapter was to select 
parameters, such as type of mediator, potential, pH, concentration of substrates, which 
would give the highest sensor response. HRP was selected to develop a model system 
due to its similarity to haemoglobin, high activity and low price. Furthermore HRP is 
one of the most commonly used enzyme in amperometric biosensors for the detection of 
H202. The model system was developed to eliminate possible, complex and overlapping 
problems resulting from lower activity of haemoglobin and electrochemical detection of 
proteins. Cyclic voltammetry and chronoamperometry methods were used for the 
peroxidase system optimisation.  
7.1 Materials and methods 
7.1.1 Reagents 
HQ (hydroquinone with CAS No: 123-31-9), hydrogen peroxide 30% (CAS No: 7722-
84-1), sodium monobasic phosphate (CAS No: 7558-80-7), sodium dibasic phosphate 
(CAS No: 7558-79-4), potassium chloride (CAS No: 7447-40-7), sodium chloride (CAS 
No: 7647-14-5), sodium hydroxide (CAS No: 1310-73-2), L-ascorbic acid (CAS No: 50-
81-7), urea (CAS No: 57-13-6), acetaminophen (CAS No: 103-90-2) and horseradish 
peroxidase type II (CAS No: 9003-99-0) were purchased from Sigma-Aldrich (Dorset, 
UK). Chemicals were used as received. 
7.1.2 Apparatus 
All electrochemical experiments were performed with the Uniscan potentiostat - 
galvanostat instrument PG580 with UiEChem software (Buxton, UK).  
 
Screen Printed Electrodes (SPE-D) were purchased from DropSens Ltd. (Oviedo, 
Spain). Three electrodes cell were purchased from BASi Electrochemistry Instruments 
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(Warwickshire, UK). Electrodes were described in Chapter 6.1.2. SPEs were used 
without any treatment. 
7.1.3 Electrochemical analysis 
All solutions used for electrochemical analysis were prepared daily. Mediators were 
prepared in a buffer deoxygenated by purging with nitrogen. Hydroquinone was used 
within 3 hours. Hydrogen peroxide was prepared in dH20 deoxygenated by purging with 
nitrogen. Mediator and hydrogen peroxide solutions were kept at 4
o
C during 
measurements. Phosphate buffer (40 mM) consisted of sodium monobasic phosphate 
and sodium dibasic phosphate and potassium chloride (100 mM). Alkaline pH was 
adjusted with 1 M sodium hydrooxide. Measurements were performed at room 
temperature (22 
o
C). 
 
Selection of mediator was made using solution containing 100 µM H202, 1.5 µg/mL 
HRP and 0.5 mM mediator. HRP and mediator stock solutions were prepared in 40 mM 
phosphate buffer, pH 7.0, with supporting electrolyte containing 100 mM KCl. 
 
The effect of applied potential was tested in the presence of 0.5 mM HQ, 200 µM H202 
and 1.5 or 100 µg/mL HRP. Peroxidase system has been optimised with HRP (100 
µg/mL). Enzyme and mediator stock solutions were prepared in 40 mM phosphate 
buffer, pH 7.0, with supporting electrolyte of 100 mM KCl. 
 
The effect of pH on the electrode response was studied in the presence of 0.5 mM 
hydroquinone, 200 µM H202 and 100 µg/mL HRP. The measured samples were 
prepared in 40 mM phosphate buffer at different pH with supporting electrolyte  
of 100 mM KCl. Mediator and HRP stock solutions were prepared in dH20 
deoxygenated by purging with nitrogen. 
 
The influence of different concentration of hydroquinone and hydrogen peroxide was 
studied in 40 mM phosphate buffer, pH 7.5, with supporting electrolyte of 100 mM 
KCl. Different concentrations of hydroquinone and hydrogen peroxide were tested with 
HRP (100 µg/mL). 
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The influence of interfering substances was studied in the presence of 0.5 or 50 mM 
hydroquinone, 200 µM H202 and 100 µg/mL HRP. Additionally measured samples 
contained 0.11 mM L-ascorbic acid, 0.17 mM acetaminophen or 4.3 mM urea. Samples 
were prepared in 40 mM phosphate buffer, pH 7.5, with supporting electrolyte  
of 100 mM KCl. 
 
Cyclic voltammetry was used for the qualitative characterisation of the peroxidise 
system. Experiments were performed on SPEs immersed in a vertical position in  
a 10 mL beaker or in the electrochemical cell with bulk electrodes. Measured samples 
were stirred for 1 minute before performing cyclic voltammetry. CV was performed 
under unstirred conditions. Experiments were run at a scan rate of 50 mV/s and the 
second cycle was analyzed. All measurements were run in duplicate. Data were 
transferred to Microsoft Office Excel and average figures calculated.  
 
Chronoamperometry was used for the peroxidase system optimisation and selection of 
parameters such as, type of mediator, applied potential, pH and concentration of 
peroxidise substrate. The effect of interferences was also investigated. SPEs were 
immersed in a vertical position in a 10 mL beaker, solutions were stirred for 1 minute 
and current was recorded. Measurements were performed in duplicate. A background 
current resulting from peroxidase substrates, hydrogen peroxide and mediator 
(H202/MED) was subtracted from a signal current resulting from the enzymatic reaction 
of horseradish peroxidase with hydrogen peroxide and mediator (H202/HRP/MED). 
Data were processed in Microsoft Office Excel and average values calculated.  
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7.2 Results and Discussion 
7.2.1 Choice of mediator 
Mediators such as hydroquinone, potassium ferrocyanide, ferrocenecarboxylic acid, 
ABTS, dichlorophenol indophenol were tested. They were previously used to construct 
hydrogen peroxide biosensors (Miao et al., 2001; Liu et al., 1996; Davis et al., 1995). 
ABTS was already recognised to react with haemoglobin and hydrogen peroxide but 
this reaction was previously detected spectrophotometrically (Everse et al., 1994).  
 
Cyclic voltammetry and chronoamperometry were used for the qualitative and 
quantitative analysis of enzymatic reaction, respectively. Measurements were performed 
in the electrochemical cell. Mediators, except dichlorophenol indophenols, in samples 
with horseradish peroxidise and hydrogen peroxide (MED/HRP/H202) showed higher 
cathodic current density in comparison to the samples which contained only mediator 
(second cycle). Also the first cycle of cyclic voltammetry for DCPIP did not show a 
positive response for an addition of an enzyme and hydrogen peroxide. DCPIP did not 
show any reduction and oxidation peak with H202 and HRP. A significant change of Epc 
was not observed for other samples containing only a mediator and samples: 
MED/HRP/H202 (Figures 41-45) The highest cathodic current density (-jpc) was 
obtained in a sample with HQ/HRP/H202, namely 157.25 µA/cm
2
 with the reduction 
peak recorded at the potential -90 mV and a difference in current between a mediator 
and a sample with MED/HRP/H202 was also the highest with HQ, namely 32.34 µA 
(Figure 41).  
 
Chronoamperometry was performed at a reduction potential. The applied potential (Epc) 
was read from CV (reduction peak potential, second cycle) for each mediator, except 
DCPIP which was studied at the potential -40 mV (first cycle). The largest current 
passage was obtained with HQ/HRP/H202 A difference in current passage between a 
background current and a signal current, recorded at the time 60 seconds was as 
follows: 9.7 µA/cm
2
 for HQ, 4.2 µA/cm
2
 for ABTS, 6.5 µA/cm
2
 for DCPIP and 0.72 
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µA/cm
2
 for potassium ferrocyanide (PFo). Trials with DCPIP showed higher current 
passage recorded for a background as compared to a signal current (Figure 46).  
 
Measurements were also performed on screen printed electrodes (SPE-D). Cyclic 
voltammetry was mainly used to obtain fast information about the electrochemical 
behaviour of chosen mediators on the SPE-D, required for further quantitative studies. 
Figures 47-51 show an electrochemical response of chosen mediators and also with 
addition of hydrogen peroxide and horseradish peroxidase. Data are summarized in 
Table 11. Redox peaks and their separation for each mediator were comparable to the 
electrochemical cell, except HQ and DCPIP which showed decreased peaks separation. 
Potential of redox peaks for samples MED and MED/HRP/H202 was not significantly 
changed. The CV of HQ and FcCOOH containing H202 and HRP showed a higher 
cathodic peak current as compared to samples with mediator, however, the difference 
was small. It might have been caused by direct, partial reduction of H202 at negative 
potentials. Cyclic voltammetry was also not sensitive enough to record higher response 
of sample (MED/HRP/H202) with chosen parameters.  The CV of DCPIP/HRP/H202 
showed characteristic two oxidation peaks and one reduction peak, however, a 
significantly lower current was recorded in comparison to a sample containing only 
DCPIP. 
 
Table 11. Analysis of cyclic voltammograms performed for mediators on SPE-D. Data 
were taken from Figures 47-50. 
 
Mediator 
Epa Epc ∆Ep 
mV 
HQ 145 -100 245 
Potassium 
Ferrocyanide 
195 70 125 
ABTS 445 350 95 
FcCOOH 260 200 60 
DCPIP 
first peak 
-30 -150 120 
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Further experiments concerned qualitative analysis of HRP activity in a presence of 
mediators and H202 using chronoamperometry method (Figure 52). Measurements were 
performed at a potential which was selected from cyclic voltammograms. The applied 
potential was -100 mV negative of the mediator reduction peak (first peak, second 
cycle). The highest enzyme response, recorded at the time 60 seconds, was obtained 
with hydroquinone (6.61 µA/cm
2
). The difference in current passage between a signal 
and background current for another mediators was calculated to be 3.11 µA/cm
2
 
(ABTS), 1.83 µA/cm
2
 (FcCOOH), 0.96 µA/cm
2
 (potassium ferrocyanide) and -4.38 
µA/cm
2
 (DCPIP). Studies which were performed with DCPIP showed a lower response 
with HRP and H202 as compared to a background current (DCPIP/H202). 
 
An increased enzymatic response and a higher difference in signal between samples: 
MED/H202 and MED/HRP/H202 can be expected with a reduced form of mediator. This 
is important especially in further studies with haemoglobin since its catalytic properties 
are not as much pronounced as in the case of peroxidase (Everse et al., 1994). Studies 
performed with hydroquinone showed the highest enzymatic response. Furthermore, its 
reduction potential should not be sensitive for oxidation of interfering substances, such 
as ascorbic acid. Therefore HQ was selected for further research.    
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Figure 41. Cyclic voltammetry of HQ (0.5 mM) and in the presence of HRP (1.5 
µg/mL) and H202 (100 µM) in PB at pH 7.0. Electrochemical cell: Au-WE, Pt-CE, 
calomel-RE. Second cycle. Scan rate 50 mV/s. 
 
 
Figure 42. Cyclic voltammetry of potassium ferrocyanide (0.5 mM) in the presence of 
HRP (1.5 µg/mL ) and H202 (100 µM) in PB at pH 7.0. Electrochemical cell: Au-WE, 
Pt-CE, calomel-RE. Second cycle. Scan rate 50 mV/s. 
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Figure 43. Cyclic voltammetry of ferrocenecarboxylic acid (0.5 mM) in the presence of 
HRP (1.5 µg/mL ) and H202 (100 µM) in PB at pH 7.0. Electrochemical cell: Au-WE, 
Pt-CE, calomel-RE. Second cycle. Scan rate 50 mV/s. 
 
 
Figure 44. Cyclic voltammetry of ABTS (0.5 mM) in the presence of HRP (1.5 µg/mL) 
and H202 (100 µM) in PB at pH 7.0. Electrochemical cell: Au-WE, Pt-CE, calomel-RE. 
Second cycle. Scan rate 50 mV/s. 
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Figure 45. Cyclic voltammetry of DCPIP (0.5 mM) in the presence of HRP (1.5 µg/mL) 
and H202 (100 µM) in PB at pH 7.0. Electrochemical cell: Au-WE, Pt-CE, calomel-RE. 
Second cycle. Scan rate 50 mV/s. 
 
 
Figure 46. Amperometric response of sensor for addition H202 (100 µM), HRP (1.5 
µg/mL) and tested mediator (0.5 mM).  
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Figure 47. Cyclic voltammetry of HQ (0.5 mM) in the presence of HRP (1.5 µg/mL) 
and H202 (100 µM) in PB at pH 7.0 on SPE-D. Second cycle. Scan rate 50 mV/s. 
 
 
Figure 48. Cyclic voltammetry of potassium ferrocyanide (0.5 mM) in the presence of 
HRP (1.5 µg/mL) and H202 (100 µM) in PB at pH 7.0 on SPE-C. Second cycle. Scan 
rate 50 mV/s. 
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Figure 49. Cyclic voltammetry of ABTS (0.5 mM) in the presence of HRP (1.5 µg/mL) 
and H202 (100 µM) in PB at pH 7.0 on SPE-D. Second cycle. Scan rate 50 mV/s. 
 
 
Figure 50. Cyclic voltammetry of DCPIP (0.5 mM) in the presence of HRP (1.5 µg/mL) 
and H202 (100 µM) in PB at pH 7.0 on SPE-D. Second cycle. Scan rate 50 mV/s. 
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Figure 51. Cyclic voltammetry of FcCOOH (0.5 mM) in the presence of HRP (1.5 
µg/mL) and H202 (100 µM) in PB at pH 7.0 on SPE-D. Second cycle.  
Scan rate 50 mV/s. 
 
 
Figure 52. Amperometric response of sensor (SPE-D) for addition H202 (100 µM), HRP 
(1.5 µg/mL) and tested mediator (0.5 mM).  
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7.2.2 Peroxidase system optimisation with HQ 
Peroxidase system optimisation was continued at SPE-D electrodes. They were 
recognized to have a good quality and also showed the best response with HQ. The area 
of working electrode (12.56 mm
2
) is sufficient to modify it with a polymer. 
Additionally, contribution of a background current such as non-faradaic current 
associated with double layer charging is lower with a smaller working electrode. It is 
essential to minimise this effect which is especially important for detecting a small 
amount of analyte. Cyclic voltammetry and chronoamperometry were used to optimise a 
system H202/HRP/HQ.  
 
Figures 53 and 54 show cyclic voltammograms for HQ and H202/HRP/HQ with 
different concentrations of HRP. Data from cyclic voltammograms are presented in 
Table 12.  The sample with HRP (100 µg/mL) showed a reduction potential of HQ 
which was shifted about 70 mV and 55 mV in comparison to the sample without HRP 
and with 1.5 µg/mL HRP, respectively. Measurements with HRP (100 µg/mL) showed 
also increased peak to peak separations, about 150 mV in comparison to measurements 
without the enzyme and decreased cathodic peak current. Most probably it was caused 
by the adsorption of protein on the electrode and its partial blocking. Results suggest 
that the adsorption process occur very fast and during about 30 seconds of the first scan. 
Similar effect caused by the adsorption of other proteins, such as human serum albumin 
(HSA) and immunoglobulin G (IgG) with the protein concentration of 100 µg/mL was 
demonstrated by Moulton et al. (2003). Cyclic voltammograms of ferricyanide showed 
wider peaks separation and decreased anodic and cathodic peak current. Peaks 
separation increased from 150 mV to 390 mV after 30 seconds of the adsorption process 
of HSA under open circuit potential and after 10 minutes, an oxidation peak of 
ferricyanide was not detected anymore (Moulton et al., 2003).  
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Table 12. Cathodic and anodic peak potential and current for a different concentration 
of HRP 
HRP Epc Epa ∆Ep ipc ipa 
µg/mL mV µA 
0 -85 115 200 -18.9 16.7 
1.5 -95 115 210 -21.4 14.05 
100 -140 210 350 -17.5 12.08 
 
 
Figure 53. Cyclic voltammetry of HQ (0.5 mM) in the presence of HRP (1.5 or 100 
µg/mL) and H202 (200 µM) in PB at pH 7.0 on SPE-D. Second cycle. Scan rate 50 
mV/s. 
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Figure 54. Cyclic voltammetry of HQ (0.5 mM) in the presence of HRP (1.5 or 100 
µg/mL) and H202 (200 µM) in PB at pH 7.0 on SPE-D. Cycle 1-3. Scan rate 50 mV/s. 
 
Chronoamperometry was applied to study an impact of different reduction potential 
(Figure 55). Table 13 shows current recorded (at approximately steady-state current) at 
the time 50 seconds at a different potential. It was observed that for the higher reduction 
potential the current recorded for the sample was higher. Significantly higher current 
was recorded for HQ/H202 and H202/HRP/HQ at a potential of -500 mV. This can be 
attributed to interferences in the system at a high potential, such as hydrogen evolution 
and partial direct reduction of H202 on the electrode.  
 
Taking into account obtained results and the fact that an electrode is likely to be fouled 
by a higher concentration of proteins, a reduction potential of -400 mV was selected for 
further experiments. The adsorption process of protein on the electrode surface slow an 
electron transfer process and therefore reactions must be driven by the application of a 
significant overpotential (Pletcher, 1991). 
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Table 13. Effect of applied potential on recorded current in samples: HQ/ H202 and 
H202/HRP/HQ. 
 HQ/H202 
Potential mV -145 -200 -300 -400 -500 
Current µA 0.02 0.03 0.03 0.14 0.7 
 H202/HRP/HQ 
Potential mV -145 -200 -300 -400 -500 
Current µA 1.62 1.79 2.00 2.37 4.29 
 
 
Figure 55. Effect of applied negative potential on electrode response in samples 
containing HQ (0.5 mM) and  H202 (200 µM) in the absence or presence of HRP (100 
µg/mL) in PB at pH 7.0. Legend: (B) – background, (S) – signal. 
 
Different pHs were tested to enhance enzymatic performance of HRP (Figure 56). The 
current recorded at approximately steady-state, at the time 50 seconds, is shown in 
Table 14.  
 
The highest current was recorded at pH 8.5 and pH 9.0. However interferences were 
visible in the system, namely current decay and its increase with time (Figure 56). The 
highest response without interferences was obtained at pH 7.5 and pH 8.0. Therefore pH 
7.5 was chosen for a further work. Furthermore, the effect of passivation might have 
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been decreased at pH above the isoelectric point of HRP which is 7.1 (data provided by 
the producer), at the negative potential. Electrostatic forces might have had an impact 
on adsorption and orientation of HRP on the electrode. The influence of electrostatic 
repulsion and attraction of proteins on a charged electrode surface was reported by Guo 
et al. (1996) and Moulton et al. (2003). Stability of protein is also an important factor 
and its denaturation at high pH may cause an easier adsorption of protein onto the 
electrode surface. 
 
Table 14. Effect of pH on recorded current at the time 50 seconds. 
Sample H202/HRP/HQ 
pH 6 6.5 7 7.5 8 8.5 9 
i (µA) 2.56 2.48 2.45 2.81 2.92 5.55 8.40 
 
 
Figure 56. Effect of pH on the peroxidase activity. Samples contained HQ (0.5 mM) in 
the presence of HRP (100 µg/mL) and H202 (200 µM) in PB buffer at the applied 
potential -400 mV. 
 
The influence of hydroquinone and hydrogen peroxide concentration was tested. It is 
important not to lower a rate of the reaction by affecting the enzyme-substrate kinetics. 
Figure 57 shows the influence of hydrogen peroxide and hydroquinone concentration on 
response (recorded current) in measured samples. Various concentrations of HQ: 0.5 
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mM, 5 mM or 20 mM showed a very similar response in a range of H202 concentrations 
from 0 to 2 mM. A significantly higher current was recorded at 50 seconds for 50 mM 
HQ. Further increase of HQ concentration to 100 mM did not show an increased current 
as compared to 50 mM HQ. Optimum concentration of HQ was estimated to be 50 mM 
and this one was selected for further research. Enzyme saturation was obtained with 4 
mM H202 and 50 mM HQ.  
 
 
Figure 57. Effect of different concentration of HQ and H202 at PB pH 7.5 in the 
presence of HRP (100 µg/mL) on its activity at 50 seconds. 
 
The influence of interfering substances was studied. Measured samples contained the 
highest physiological concentration of interfering substances found in blood, namely 
0.11 mM L-ascorbic acid, 0.17 mM acetaminophen, and 4.3 mM urea (Moussy et al., 
1993).  
 
Figures 58-59 and Table 15 show the influence of interfering substances on current 
response at a potential of -400 mV measured at the time 50 seconds. The highest 
influence was observed with ascorbic acid. Samples of ascorbic acid, acetaminophen or 
urea in the presence of HRP/HQ showed the highest current in comparison to the 
samples containing HQ/H202 (except samples ascorbic/HRP/HQ/H202 and 
HQ/HRP/H202). Probably ascorbic acid reacted with quinone which was produced in the 
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enzymatic reaction. Quinone was presumably reduced with ascorbic acid, instead of 
being reduced on the electrode. Research performed by Miao et al. showed a reduction 
of potassium ferricyanide by ascorbic acid (Miao et al., 2001). There was no significant 
influence of interfering substances on a sensor response in the sample with HRP and 
H202. Results may suggest that these substances do not undergo oxidation or reduction 
process on the electrode. Figure 60 shows a difference in current between samples: 
ascorbic/HRP/HQ and ascorbic/HRP/HQ/H202 with different concentration of H202. The 
highest concentration of hydrogen peroxide produced the highest sensor response. The 
highest difference in current was obtained for 4.0 mM H202: 36.9 µA (Figure 60). 
 
Table 15. Effect of interfering substances on a sensor response. 
  i(µA) 
HQ 0.15 
HQ/H202 0.18 
HRP/H202 0.39 
Ascorbic/HRP/HQ 1.07 
Urea/HRP/HQ 0.9 
Acetaminophen/HRP/HQ 0.83 
Ascorbic/HRP/ H202 0.25 
Urea/HRP/ H202 0.37 
Acetaminophen/HRP/ H202 0.59 
Ascorbic/HRP/HQ/ H202 1.86 
HQ/HRP/ H202 3.38 
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Figure 58. Interferences caused by L-ascorbic acid. Samples contained HQ (0.5 mM), 
HRP (100 µg/mL) H202 (200 µM), L-ascorbic acid (0.11 mM) in PB pH 7.5 at the 
applied potential -400 mV. 
 
 
Figure 59. Interferences in the samples containing HQ (0.5 mM), HRP (100  µg/mL), 
H202 (200 µM), L-ascorbic acid (0.11 mM) or acetaminophen (0.17 mM) or urea (4.3 
mM) in PB pH 7.5 at the applied potential -400 mV. 
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Figure 60. Interferences caused by L-ascorbic acid. Samples contained L-ascorbic acid 
(0.11 mM), HQ (50 mM), HRP (100 µg/mL) and H202 in PB pH 7.5 at the applied 
potential -400 mV at 50 seconds. 
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7.2.3 Conclusions 
In this chapter a model system was developed and parameters were optimised for 
research on electrochemical determination of haemoglobin. Parameters, such as 
hydroquinone concentration (50 mM), concentration of H202 (4 mM), pH of phosphate 
buffer (pH 7.5) and the reduction potential (-400 mV) were selected for further 
experiments. These parameters contributed to a maximal sensor response and a small 
influence of interfering substances, such as ascorbic acid. 
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Chapter 8: Electrochemistry of haemoglobin  
8.1 Materials and methods 
8.1.1 Reagents 
Potassium ferricyanide (CAS No: 13746-66-2), MB (Methylene Blue, CAS No: 7220-
79-3), HQ (hydroquinone with CAS No: 123-31-9), hydrogen peroxide 30% (CAS No: 
7722-84-1), carboxylmethyl cellulose sodium salt (CAS No: 9004-32-4), sodium 
monobasic phosphate (CAS No: 7558-80-7), sodium dibasic phosphate (CAS No: 7558-
79-4), potassium chloride (CAS No: 7447-40-7), sodium chloride (CAS No: 7647-14-5), 
sodium hydroxide (CAS No: 1310-73-2), phosphate buffer saline tablet, Sephadex G-25 
fine (CAS No: 9041-35-4), haemoglobin bovine (CAS No: 9008-02-0), haemoglobin 
human (CAS No: 9008-02-0), Drabkin’s Reagent, 30% Brij 35 solution (9002-92-0) 
were purchased from Sigma-Aldrich (Dorset, UK). Chemicals were used as received. 
Human blood was collected into tubes containing EDTA as an anticoagulant. Human 
blood was kept at 4 
o
C and used within two weeks. 
8.1.2 Apparatus 
All electrochemical experiments were performed with the Uniscan potentiostat - 
galvanostat instrument PG580 with UiEChem software (Buxton, UK). The Uniscan 
instrument was used with a beaker or an electrochemical cell which consisted of Screen 
Printed Electrodes (SPE) or a three electrode cell, respectively.  
 
The three electrode cell consisted of a gold (A=2.01 mm
2
) as a working electrode and 
platinum (A=2.01 mm
2
) as a counter electrode and calomel as a reference electrode. 
They were purchased from BASi Electrochemistry Instruments (Warwickshire, UK). 
Calomel electrode was purchased from Sigma-Aldrich (Dorset, UK). The gold and 
platinum electrodes were cleaned after each measurement. Electrodes were cleaned 
firstly with alumina 0.3 µm particle on a polishing pad and thoroughly rinsed with 
distilled water (dH20). Then the electrode was polished on a polishing pad soaked with 
dH20 and thoroughly rinsed with dH20. Screen Printed Electrodes (SPE-D) and Screen 
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Printed Electrodes - Carbon Nanotubes (SPE CNT-D) were purchased from DropSens 
Ltd. (Oviedo, Spain). Other type of SPEs (SPE-P) was provided by Pelikan 
Technologies Inc. Electrodes were described in details in Chapter 6.1.2. SPEs were used 
without any pre-conditioning or the working electrode surface was modified with 0.5% 
solution of carboxylmethyl cellulose sodium salt. Also a gold electrode was modified 
with carboxylmethyl cellulose. CMCNa was used to avoid electrode passivation caused 
by haemoglobin. CMCNa was prepared in dH20 and used for modification of working 
electrode surface. 15 µL of CMCNa was put on SPE-D sensors, 5 µL on SPE-P sensors 
and the gold electrode. Electrodes were dried 30 minutes in the desiccator at room 
temperature (24 
o
C).  
 
The following other equipment was used in experiments: Flow-Cell for screen-printed 
electrodes (wall-jet type) from DropSens (Oviedo, Spain); Minipuls3  Peristaltic Pump 
Gilson (Middleton, USA); injector Valve V-7 was purchased from GE Healthcare 
(Amersham, UK); PD-10 column was provided by Sigma-Aldrich (Dorset, UK); 
Amicon ultra-15 and ultra-4 centrifuge filter (30 kDa cut-off) was provided by Millipore 
Ltd. (Watford, UK); centrifuge, Jouan B4i was purchased from Thermo Fisher 
Scientific (Waltham, USA); spectrophotometer, Shimadzu 2100 (Shimadzu, Kyoto, 
Japan) and pH-meter, Hanna Instruments 8519 was purchased from Hanna Instruments 
Inc. (Woonsocket, USA). 
8.1.3 Haemoglobin isolation from blood 
Isolation of Hb was performed at 5 
o
C and purification step was performed at 22
 o
C.  
2 mL of human blood was mixed with 6 mL of NaCl (0.9%). Solution was centrifugated 
for 10 minutes at 1620 g. Supernatant (plasma) was discarded and the washing 
procedure with NaCl repeated three times. Red blood cells (RBCs) were collected, 
mixed with 11 mL of distilled water and left for 10 minutes for hemolysis. Solution was 
centrifugated for 40 minutes at 2880g. Clear, red supernatant containing haemoglobin 
was collected. Haemoglobin was purified passing over the column which was packed 
with Sephadex G-25. 2.5 mL of Hb sample was loaded onto the column and eluted with 
PBS buffer.  Hb solution was concentrated on amicon ultra-15 centrifugal filter unit 30 
kDa cut-off. Filter unit was rinsed with dH20 to remove trace amounts of triethylene 
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glycol and filled with 15 mL of the sample. Centrifugation took 30 minutes at 2880 g. 
The content of Hb was determined by Drabkin’s method.   
8.1.4 Spectrophotometric determination of Hb by Drabkin's method 
Spectrophotometric determination of Hb was performed according to the Sigma 
procedure. Drabkin’s solution was prepared by reconstitution of one vial of Drabkin’s 
Reagent with 1000 mL of water. Then 0.5 ml of the 30% Brij 35 solution was added. 
The prepared Drabkin’s solution was kept at room temperature 22 oC and was protected 
from light. Cyanmethemoglobin standard solution was prepared. It contained 180 
mg/mL of human haemoglobin (Hb purchased from Sigma, containing mainly HbFe
3+
) 
in Drabkin’s solution. Cyanmethemoglobin standard solution was diluted as required. 
40 μl of the prepared cyanmethemoglobin standard solution was added to 10 mL of the 
Drabkin’s solution. Working standard solutions were prepared by dilution in Drabkin’s 
solution. Absorbance was read versus Drabkin’s solution as a reference at 540 nm and 
calibration curve of absorbance value versus cyanmethemoglobin concentration was 
plotted. 5 mL of the Drabkin’s solution was added to test and blank tubes. Then 20 µL 
of the whole blood sample was added to test tubes. They were mixed well and left for 
20 minutes at room temperature 20 °C. Absorbance was read for test tubes versus the 
blank as the reference at 540 nm and total haemoglobin concentration (mg/mL) of each 
test was determined from the calibration curve. 
8.1.5 Electrochemical analysis 
All solutions used for electrochemical analysis were prepared daily. Mediators, 
hydrogen peroxide and haemoglobin stock solutions were kept in +4 
o
C during 
measurements. All experiments were performed at room temperature (22
 o
C).  
 
Peroxidase activity of HbFe
3+ 
was studied with HQ (50 mM) and H202 (4 mM) in 
deoxygenated or non-deoxygenated phosphate buffer, pH 7.5. Mediator and HbFe
3+
 
stock solutions were prepared in a deoxygenated phosphate buffer. Mediator solution 
was used within 3 hours. Additionally hydroquinone stock solution was deoxygenated 
by purging with nitrogen over the solution for 5 minutes. Hydrogen peroxide solution 
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was prepared in deoxygenated dH20. All solutions were deoxygenated by purging with 
nitrogen. Stock solutions were kept in +4 
o
C during measurements. Phosphate buffer 
(40 mM) consisted of sodium monobasic phosphate, sodium dibasic phosphate and 
potassium chloride (100 mM), pH 7.5. 
 
Potassium ferricyanide, methylene blue and HbFe
3+
 stock solutions were prepared in 
deoxygenated PBS, pH 7.4. Phosphate Buffer Saline, pH 7.4 was prepared by dissolving 
one tablet per 200 mL of dH20.  
 
Two voltammetric techniques were used to investigate electrochemical behaviour and 
detection of haemoglobin. Cyclic voltammetry was used for the qualitative 
characterisation of electrodes coated with polymer. Chronoamperometry was used for 
the detection of Hb (HbFe
3+ 
and HbFe
2+
). 
 
Cyclic voltammetry experiments were performed at a scan rate 50 mV/s, starting from 
negative towards positive potentials, except methylene blue measurements which were 
started from positive potentials. Measurements were performed on SPEs immersed in a 
vertical position in a 10 mL beaker or measurements were performed in a 10 mL 
electrochemical cell, which consisted of a gold working electrode, a platinum counter 
electrode and a calomel reference electrode. Studies concerning a choice of oxidation 
potential for potassium ferricyanide and electrodes were performed on SPEs immersed 
in a vertical position in a 5 mL beaker. Measured samples were stirred for 1 minute 
before cyclic voltammetry. CV was performed under unstirred conditions. All 
measurements were run in triplicate. Data were transferred to Microsoft Office Excel 
and average values calculated.  
 
Chronoamperometric studies on peroxidase activity of haemoglobin were performed in 
three different configurations. Initially SPEs electrodes were immersed in a vertical 
position in a 10 mL beaker with studied samples which consisted of HbFe
3+
, H202 and 
mediator. Solution was stirred for 10 seconds and current recorded. Enzymatic activity 
was also investigated by applying a drop on the electrode. 120 µL of studied solution 
was mixed for 20 seconds and placed on the electrode. Current was recorded at a 
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potential of -400 mV.  Further experiments were focused on detection of haemoglobin 
in an FIA system at a flow rate 0.5 ml/min. The FIA system was made up of the 
peristaltic pump, the injector and the flow cell. Samples containing HQ, H202 with or 
without Hb were injected into the loop (50 µL). Samples were prepared in a phosphate 
buffer, pH 7.5 and mixed 20 seconds before injection into the running phosphate buffer. 
Measurements were performed in triplicate. Data were processed in Microsoft Office 
Excel and average values calculated.  
 
Studies concerning HbFe
2+
 detection with potassium ferricyanide were performed at 
SPE CNT-D electrodes. Samples which consisted of mediator and different 
concentration of haemoglobin were incubated for 5 minutes. Afterwards 100 µL of 
solution was placed on the electrode surface and current was recorded.  
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8.2 Results and Discussion 
8.2.1 Electrochemical detection of haemoglobin using its peroxidase 
activity 
The selection of parameters for Hb detection was based on results obtained with HRP. 
The chronoamperometric signal was measured at a negative reduction potential of -400 
mV on SPE-D electrodes. Haemoglobin (HbFe
3+
) detection was performed with HQ (50 
mM) and H202 (4 mM). 
 
Detection of haemoglobin was obtained with three different setups. Amperometric 
response for different concentrations of haemoglobin is shown in Figures 61-64. A 
linear calibration curve was obtained for Hb detection in a range from 0.05 to 2 mg/mL 
(Figures 65-67). 
 
Initial experiments were performed on SPE-D electrodes immersed in a beaker and also 
by placing a drop of tested solution on an electrode. Measurements were performed 
under diffusion control. Measured samples gave a calibration curve described by the 
equation: y = 6.84E-06x + 1.21E-06 and R
2
 = 0.9938 for a beaker setup. The 
amperometric signal was analysed at the time 5 seconds. The characteristic Cottrell 
behaviour was obtained. However, a deviation from this behaviour is visible after about 
100 seconds of experiments (Figure 61) when increased current was detected. It may be 
attributed to the natural convection that can occur after longer time (over 100 seconds) 
due to coupled chemical reactions (Wang, 2006). To avoid natural convection current 
may be recorded in a very short period of time.  However problems could result from 
possible interferences if the data are taken from the first seconds of the experiment 
where non steady-state current is observed. The recorded current is a result of faradaic 
current and also a charging current (Pletcher, 1991).  
 
The calibration curve was described by: y = 9.82E-06x + 3.12E-06 and R
2 
= 0.9784 for 
haemoglobin detection on the SPE with 120 µL drop of studied solution and analysed at 
the time 5 seconds (Figure 65).  Calibration curves plotted after a longer time (50 
seconds) showed lower sensitivity and were characterised by the equation:  
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y = 7.17E-06x + 6.04E-07, R2 = 0.9739 (Figure 66). Reduction of quinone on the 
electrode surface might have been limited by mass transport, especially at the applied 
high potential in the experiment.  
 
Further studies were performed in the flow injection analysis system (FIA) where the 
mass transport is not a limiting step. Measurements described by equations: y = 1.97E-
05x + 4.21E-06, R2 = 0.982 and y = 1.89E-05x + 4.43E-05, R2 = 0.983 were performed 
in the flow cell with a deoxygenated or non-deoxygenated buffer as a carrier solution, 
respectively (Figures 63, 64, 65 and 67). Higher background current was observed for 
successive injections of samples into a non-deoxygenated stream of carrier solution, 
however, the sensitivity of the sensor was not significantly decreased (Figure 64). The 
highest sensitivity was obtained in the FIA system in comparison to previous 
experiments. Experiments could also have been performed in a stirred solution. 
However, measurements could be sensitive to the disturbances in the system.  
 
The reduction potential (-400 mV) and also pH 7.5 might have had a positive impact on 
obtained results. Probably electrode fouling was decreased due to electrostatic forces 
(repulsion) resulting from negatively charged haemoglobin at pH above its isoelectric 
point and the negative reduction potential. This effect may be less pronounced at higher 
protein concentrations. A significant decrease of current passage was detected for Hb 
(50 mg/mL) which was comparable to the signal recorded for 2 mg/mL of Hb (Figure 
62). Detection of haemoglobin over a short time could minimize the fouling effect. An 
oxidised form of mediator can be also tested since the enzymatic reaction is fast. 
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Figure 61. Amperometric response for sample containing different concentration of 
HbFe
3+
 (mg/mL), HQ (50 mM), H202 (4 mM). SPE-D immersed in a beaker. Signal 
recorded at a reduction potential -400 mV. 
 
 
Figure 62. Amperometric response for sample containing different concentration of 
HbFe
3+
 (mg/mL), HQ (50 mM), H202 (4 mM) at a potential -400 mV. 120 µL of studied 
solution on SPE-D.  
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Figure 63. Amerometric response of successive injections of sample (50 µL) containing 
HQ (50 mM), H202 (4 mM) and HbFe
3+
 (from 0 to 5 mg/mL) on SPE at a potential  
-400 mV. Carrier solution: deoxygenated PB (pH 7.5). Flow rate 0.5 mL/min. 
 
 
Figure 64. Amerometric response of successive injections of sample (50 µL) containing 
HQ (50 mM), H202 (4 mM) and HbFe
3+
 (from 0 to 5 mg/mL) on SPE at a potential         
-400 mV. Carrier solution: non-deoxygenated PB (pH 7.5). Flow rate 0.5 mL/min 
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Figure 65. Detection of HbFe
3+
 using its peroxidase activity with HQ (50 mM), H202  (4 
mM) in deoxygenated PB at pH 7.5 on SPE-D at a potential -400 mV. Amperometric 
signal recorded at the time 5 seconds in a drop or beaker setup. 
 
 
Figure 66. Detection of HbFe
3+
 using its peroxidase activity with HQ (50 mM), H202  (4 
mM) in deoxygenated PB at pH 7.5 on SPE-D at a potential -400 mV. Amperometric 
signal recorded at 50 seconds in a drop or beaker setup. 
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Figure 67. Detection of HbFe
3+
 using its peroxidase activity with HQ (50 mM), H202  (4 
mM) in non-deoxygenated PB at pH 7.5 on SPE-D at a potential -400 mV in the FIA 
system. 
 
8.2.2 Electrochemical detection of haemoglobin with mediator 
A simplified system based only on reaction between haemoglobin and mediator was 
also investigated. Initial experiments included detection of HbFe
3+
. Measurements were 
performed with the electrochemical cell in PBS buffer pH 7.4. Cyclic voltammetry was 
used for HbFe
3+
 detection. The concentration of methylene blue and potassium 
ferricyanide was 0.5 and 100 mM, respectively. 
 
Measured samples which contained only potassium ferricyanide gave higher anodic and 
cathodic peak current and also they showed a smaller peak-to-peak separation (Figure 
68 and Table 16). The highest peak separation was detected for 3.23 mg/mL Hb. Also 
the oxidation and reduction peaks became less steep. This was caused by electrode 
fouling with haemoglobin. Additionally, mediators such as potassium ferricyanide and 
methylene blue must be previously reduced to be able to react with HbFe
3+
. 
Furthermore reaction between HbFe
3+
 and potassium ferrocyanide occurs to a small 
extent (Iorio, 1981).  
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Table 16. Analysis of cyclic voltammgram for sample containing potassium 
ferricyanide (100 mM) and different concentration of HbFe
3+
. 
HbFe
3+
 Epa Epc ∆Ep 
mg/mL mV 
0 350 135 215 
0.65 460 10 450 
1.29 390 10 380 
3.23 520 -115 635 
 
 
Figure 68. Cyclic voltammetry of potassium ferricyanide (100 mM) with different 
concentration of HbFe
3+
 (from 0 to 3.23 mg/mL) in PBS at pH 7.4 Electrochemical cell: 
Au-WE, CE-Pt, calomel-RE. Scan rate 100 mV/s. Second cycle. 
 
Cyclic voltammetry performed with methylene blue and haemoglobin showed anodic 
and cathodic peaks at the same potential without significant difference from 
measurements performed only with methylene blue. Leucomethylene blue is recognized 
to be able to reduce HbFe
3+
 and it is a reversible reaction (Bradberry S.M., 2003). 
However it was still impossible to detect haemoglobin with cyclic voltammetry, only an 
insignificant increase in cathodic current response was obtained in the sample 
MB/HbFe
3+
 (Figure 69).  
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Figure 69. Cyclic voltammetry of MB (0.5 mM) with different concentration of HbFe
3+
 
(from 0 to 3.23 mg/mL) in PBS at pH 7.4 Electrochemical cell: Au-WE, CE-Pt, 
calomel-RE scan rate 50 mV/s. 
 
Further work was focussed on the detection of HbFe
2+
 with potassium ferricyanide 
using chronoamperometry method. Preliminary studies were performed with cyclic 
voltammetry to choose electrodes and to select an oxidation potential for potassium 
ferricyanide. Electrodes which showed good characteristic (Chapter 6.2.2) were tested 
to verify an effect of haemoglobin and potassium ferricyanide on a sensor response. An 
attempt was made to decrease a passivation effect and to operate a sensor at the lowest 
oxidation potential. Cyclic voltammetry was used for the studies with an applied scan 
rate 50 mV/s. Measurements were performed with 9.35 mg/mL HbFe
2+
 and 50 mM 
potassium ferricyanide in the sample. Cyclic voltammetry was performed on different 
electrodes: SPE-D, SPE CNT-D, SPE-P and also with the electrochemical cell. A 
working electrode surface was modified with CMCNa and compared to an unmodified 
electrode.  
 
Cathodic and anodic peaks showed lower current in the second and third cycle on SPE 
DropSens electrodes and the electrochemical cell with and also without CMCNa layer 
on the gold electrode (Figures 71-76). Samples with potassium ferricyanide and HbFe
2+ 
showed significantly higher oxidation and reduction current peaks in the first cycle in 
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comparison to the second and third cycle in the electrochemical cell (Figure 71, Table 
17). 
 
Table 17. Cyclic voltammetry of 50 mM potassium ferricyanide and 9.35 mg/mL  
HbFe
2+
. 
cycle 
number 
ipa ipc 
i(µA) 
1 94.5 -77.2 
2 70.3 -63.3 
3 63 -61.2 
 
Peak to peak separation was higher with each cycle on tested electrodes in comparison 
to the samples with mediators (Figures 71-76). SPE DropSens electrodes showed a 
different position of anodic and cathodic peaks of samples with potassium ferricyanide 
and HbFe
2+
 in comparison to the sample containing only mediator (Figures 72-74). 
Table 18 indicates the position of the oxidation and reduction potential peaks and their 
separation for samples containing potassium ferricyanide and haemoglobin in the 
following cycles. 
 
It was suggested by researchers that CMCNa can protect an electrode against fouling by 
haemoglobin and also can bring haemoglobin closer to the electrode (Jiang et al., 2005). 
However, the research presented in this report showed that the modification of working 
electrode surface did not have a significant positive effect on cyclic voltammetry of 
potassium ferricyanide. Electrode modification with CMCNa on the gold electrode 
showed some protection against passivation in comparison to the SPEs sensors. Cyclic 
voltammetry exhibited smaller anodic and cathodic peak separation with each cycle 
compared to the SPE electrodes (Table 18). However, passivation was still noticable 
during experiments (Figure 71). These results indicate that a polymer layer coated on 
the electrode may help to avoid passivation, at least partially. Layer CMCNa was not 
clearly visible on SPEs electrodes and possibly did not form a good quality coating. 
SPE-P showed the largest peak separation and the highest oxidation potential in each 
cycle (Table 18, Figures 75-76).  
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Table 18. Cyclic voltammograms of potassium ferricyanide and HbFe
2+
 on different 
SPEs in cycles 1-3. 
cycle number 1 2 3 
  
Epa Epc ∆Ep Epa Epc ∆Ep Epa Epc ∆Ep 
mV 
EC CMCNa 260 55 205 345 -25 370 420 -75 495 
SPE-D CMCNa 105 -490 595 185 -550 735 245 -580 825 
SPE-D 130 -475 605 190 -545 735 250 -580 830 
SPE-D CNT 115 -500 615 180 -540 720 225 -560 785 
SPE-P CMCNa 635 -645 1280 675 -695 1370 700 -680 1380 
SPE-P 695 -635 1330 705 -695 1400 725 -750 1475 
 
The most convenient oxidation potential (less susceptible for interferences) was 
obtained with SPE CNT DropSens with haemoglobin (225 mV for the third cycle). 
Cyclic voltammetry for ferricyanide on these electrodes showed a current increase in the 
following cycles 1-3 (Figure 74), probably as a result of enhanced electron transfer 
produced by nanotubes (Yan et al, 2005; Zhao et al., 2005).  The mentioned reaction is 
not enzymatic and therefore it can be assumed that higher oxidation of haemoglobin 
will be obtained over a longer period of time. Therefore it is possible to obtain higher 
response of sensor with time, due to the more efficient reaction and enhanced properties 
of these electrodes. It was also necessary to perform experiments with HbFe
2+
 in a small 
sample volume due to difficulties in purifying a large amount of HbFe
2+
. This is 
especially essential working with HbA1c and also HbA0. Therefore SPE CNT 
DropSens electrodes were chosen for haemoglobin detection with potassium 
ferricyanide. 
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Figure 70. Cyclic voltammetry of potassium ferricyanide (50 mM) in PBS at pH 7.4 
Electrochemical cell: Au modified with CMCNa-WE, CE-Pt, calomel-RE.  
Scan rate 50 mV/s. Cycle1-5. 
 
 
Figure 71. Cyclic voltammetry of potassium ferricyanide (50 mM) in the presence of 
HbFe
2+
 (9.35 mg/mL) in PBS at pH 7.4 Electrochemical cell: Au modified with 
CMCNa-WE, CE-Pt, calomel-RE. Scan rate 50 mV/s. Cycle1-3. 
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Figure 72. Cyclic voltammetry of potassium ferricyanide (50 mM) in the presence of 
HbFe
2+
 (9.35 mg/mL) in PBS at pH 7.4 on SPE-D. Scan rate 50 mV/s. Cycle1-3. 
 
 
Figure 73. Cyclic voltammetry of potassium ferricyanide (50 mM) in the presence of 
HbFe
2+
 (9.35 mg/ mL) in PBS at pH 7.4 on SPE-D modified with CMCNa. Scan rate 50 
mV/s. Cycle1-3. 
 
 102 
 
 
Figure 74. Cyclic voltammetry of potassium ferricyanide (50 mM) in the presence of 
HbFe
2+ 
(9.35 mg/mL) in PBS at pH 7.4 on SPE CNT-D. Scan rate 50 mV/s. Cycle1-3. 
 
 
Figure 75. Cyclic voltammetry of potassium ferricyanide (50 mM) in the presence of 
HbFe
2+
 (9.35 mg/mL) in PBS at pH 7.4 on SPE-P. Scan rate 50 mV/s. Cycle1-3. 
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Figure 76. Cyclic voltammetry of potassium ferricyanide (50 mM) in the presence of 
HbFe
2+
 (9.35 mg/mL) in PBS at pH 7.4 on SPE-P modified with CMCNa. Scan rate 50 
mV/s. Cycle1-3. 
 
HbFe
2+
 detection with potassium ferricyanide was performed with a 
chronoamperometric method on SPE CNT-D electrodes at the oxidation potential of 
+500 mV (Figure 77). The potassium ferricyanide concentration used was 50 mM in the 
samples. A calibration curve recorded at 30 seconds was characterised by the equation  
y = 1.44E-07x – 2.54E-09 and R2=0.9998. A detection range from 0.83 to 83 mg/mL 
was obtained. The RSD was calculated to be 3.55 % for 10 electrodes (Figure 78). The 
linearity and detection range was improved with potassium ferricyanide as compared to 
the HQ/H202 sensor for haemoglobin detection. However, trials with potassium 
ferricyanide showed also a lower sensitivity and a higher detection limit (Figures 65 and 
78).  
 
Studies performed by Jiang et al. suggested that the reaction between potassium 
ferricyanide and haemoglobin is immediate and the current signal is proportional to the 
content of haemoglobin. Researchers also showed that detection can be performed in an 
oxygen environment (Jiang et al., 2005). However, the reaction can be stronger in an 
oxygen free environment (Bradberry, 2003). A larger overpotential +500 mV was 
applied to enhance electron transfer and reduce passivation. However interferences 
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resulting from an oxidation of substances such as ascorbic acid and acetaminophen are 
significant at this potential. Oxidation potential of these substances is around +400 mV 
vs Ag/AgCl (Wang et al., 1998). Furthermore, interferences can be caused by the 
reaction of potassium ferricyanide and ascorbic acid (Miao et al., 2001). 
 
Reaction with other mediators such as ferrocenecarboxylic acid (Chen et al., 2003), 
methylene blue (Brett et al., 1999), quinone (Winterbourn, 1985), capable to react with 
HbFe
2+
 is also a possible route forward. Reaction with quinone may be performed only 
in a deoxygenated environment due to side reactions with oxygen (Winterbourn, 1985). 
 
 
Figure 77. Sensor response for a different concentration of HbFe
2+
 (mg/mL) with 
potassium ferricyanide (50 mM) in PBS (pH 7.4). Sample was incubated 5 minutes and 
current recorded at a potential +500 mV. 
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Figure 78. Detection of haemoglobin (HbFe
2+
) with potassium ferricyanide (50 mM) in 
PBS at pH 7.4 on SPE CNT-D at a potential +500 mV. 
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8.3 Conclusions 
The model system based on horseradish peroxidise, was successfully used for 
detection of haemoglobin. Reduced or oxidized forms of haemoglobin (HbFe2+ or 
HbFe3+) can be detected using its peroxidase activity by chronoamperometry. 
Haemoglobin (HbFe2+) can be also detected by its reaction with potassium ferricyanide. 
However, a faster response, a higher sensitivity and a lower detection limit were 
obtained using the enzymatic reaction of Hb. Increased current density resulting from 
the reaction catalysed by Hb suggested a way to construct a MIPs-based sensor.  
 
Passivation, caused by a high concentration of haemoglobin is overcomed by an 
application of significant overpotential. Therefore, cyclic voltammetry is not suitable 
for detection of haemoglobin, even at a very low protein concentration using its 
peroxidase activity. 
 
Interferences caused by substances such as ascorbic acid, acetaminophen, uric acid 
and urea can be minimized, but it is impossible to avoid them completely. Therefore, it 
may be useful to incorporate a purification or separation step in a functional Hb-
meter. 
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Chapter 9: MIP technology for recognition of HbA0 / HbA1c  
9.1 Haemoglobin detection on SPE modified with polymer 
9.1.1 Materials and methods 
9.1.1.1 Reagents 
HQ (hydroquinone with CAS No: 123-31-9), hydrogen peroxide 30% (CAS No: 7722-
84-1), sodium monobasic phosphate (CAS No: 7558-80-7), sodium dibasic phosphate 
(CAS No: 7558-79-4), potassium chloride (CAS No: 7447-40-7), APBA (CAS No: 
206658-89-1), ammonium persulfate (CAS No: 7727-54-0), sodium hydroxide (CAS 
No: 1310-73-2) were purchased from Sigma-Aldrich (Dorset, UK), glycated 
haemoglobin (HbA1c) and non-glycated haemoglobin (HbA0) were purchased from 
Exocell, Inc. (Philadelphia, USA). Chemicals were used as received. 
 
9.1.1.2 Apparatus 
All electrochemical experiments were performed with the Uniscan potentiostat - 
galvanostat instrument PG580 with UiEChem software (Buxton, UK).  
 
Screen Printed Electrodes (SPE-D) were purchased from DropSens Ltd. (Oviedo, 
Spain). Three electrodes cell were purchased from BASi Electrochemistry Instruments 
(Warwickshire, UK). Electrodes were described in Chapter 6.1.2. SPEs were either used 
without any treatment or the working electrode surface was modified with APBA by 
chemical polymerisation.  
 
The following other equipment was used in experiments: Flow-Cell for screen-printed 
electrodes (wall-jet type) from DropSens (Oviedo, Spain); Minipuls3  Peristaltic Pump 
Gilson (Middleton, USA); injector Valve V-7 was purchased from GE Healthcare 
(Amersham, UK); centrifuge, Jouan B4i was purchased from Thermo Fisher Scientific 
(Waltham, USA); spectrophotometer, Shimadzu 1800 (Shimadzu, Kyoto, Japan); pH-
meter, Hanna Instruments 8519 was purchased from Hanna Instruments Inc. 
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(Woonsocket, USA); Amicon ultra-4 centrifuge filter (30kDa cut-off) was provided by 
Millipore Ltd. (Watford, UK); pump tubes PVC (I.D. 1.42 mm) Anachem Ltd. (Luton, 
UK); PTFE tubing (I.D. 0.8 mm), 1/4-28 Tube Endfitting (Nut), gripper fitting were 
purchased from Omnifit Ltd. (Cambridge, UK). 
 
9.1.1.3 Surface grafted polymer on SPE for recognition of HbA0 and 
HbA1c  
Procedure for grafting of APBA, previously developed at Cranfield University was 
modified and applied with SPE-D electrodes. Non-imprinted polymer (NIP) was grafted 
on the electrode by means of chemical polymerisation which was carried out by 
oxidation with ammonium persulfate. Ammonium persulfate was dissolved in distilled 
water. APBA was dissolved in distilled water by heating at 47
◦
C and stirring for 10 
minutes. 15 µL of APBA (100 mM) was placed on the working electrode (WE) and 15 
µL of ammonium persulfate (50 mM) was added. Polymerisation was carried out for 30 
minutes. Electrodes were thoroughly rinsed with dH20 and 7 times with buffer. Washing 
buffer consisted of 3% acetic acid and 0.1% Tween 20. 300 µL of the buffer was 
pipetted onto the electrode. Electrodes were conditioned in sodium phosphate buffer 
(50mM) with Tween 20 (0.1%) at pH 7.0 for 30 minutes. 
 
SPE electrodes were coated with a molecularly imprinted polymer layer (MIP) by 
chemical polymerisation. 15 µL of APBA / Hb solution was placed on the working 
electrode and 15 µL ammonium persulfate (50 mM) was added. Haemoglobin was 
dissolved in APBA solution. Concentration of template (Hb) was 1 mg/mL and molar 
ratio, APBA: ammonium persulfate was 2:1. Polymerisation and washing procedure 
was the same as described above for preparation of NIP electrodes. 
9.1.1.4 Electrochemical analysis 
All solutions used for electrochemical analysis were prepared daily. Mediator was 
prepared in a buffer deoxygenated by purging with nitrogen. Additionally mediator 
stock solution was deoxygenated by blowing nitrogen over the solution for 5 minutes 
and used within 3 hours. Hydrogen peroxide was prepared in dH20 deoxygenated by 
purging with nitrogen. Mediator and hydrogen peroxide were kept in 4
o
C during 
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measurements. Phosphate buffer (40 mM) consisted of sodium monobasic phosphate 
and sodium dibasic phosphate and potassium chloride (100 mM). pH was adjusted with 
1 M sodium hydrooxide. All measurements were performed at room temperature 
(22
o
C). 
 
Cyclic voltammetry was used for the qualitative characterisation of electrodes coated 
with polymer. Experiments were performed on SPE electrodes without modification, 
SPE modified with non-imprinted polymer (NIP), SPE modified with imprinted 
polymer (MIP). Electrodes were immersed in a vertical position in a 10 mL beaker. CV 
was performed under unstirred conditions. All measurements were run in triplicate. 
Data were transferred to Microsoft Office Excel and average values calculated. Three 
cycles were performed for each electrode at a scan rate 50 mV/s. All Figures show the 
second cycle. Voltammograms were run from negative toward positive potentials. 
 
Chronoamperometry was used for detection of haemoglobin. Experiments were 
performed on SPE electrodes, SPE covered with non-imprinted polymer (NIP), SPE 
modified with imprinted polymer (MIP), SPE modified with imprinted polymer 
containing HbA0 as a template (MIP-0), SPE modified with imprinted polymer 
containing HbA1c as a template (MIP-1c). Experiments were performed in a FIA-
system (Flow Injection Analysis) at a flow rate 0.5 ml/min. The FIA system was made 
up of the peristaltic pump, the injector and the flow cell. Samples containing HQ 
(hydroquinone), H202 with or without Hb were injected into the loop (50 µL). Carrier 
solution (PB buffer, pH 6.0; 7.0; 7.5 or 8.0) was pumped by a peristaltic pump through 
the injector. PTFE tube (I.D. 0.8 mm, length 27 cm) was connected to the outlet of the 
injector and to the flow cell. Samples were prepared in phosphate buffer and mixed for 
20 seconds before injection. Measurements were performed in triplicate. Data were 
processed in Microsoft Office Excel and average Figures calculated.  
 
  
 110 
 
9.1.2 Results and Discussion 
9.1.2.1 Characetrization of SPEs coated with polymer 
Measurements were performed in 40 mM phosphate buffer pH 7.5 with supporting 
electrolyte 100 mM KCl. Measured samples contained 0.5 or 50 mM HQ, 4 mM H202, 
0.3 mg/mL HbFe
3+
. 
 
Cyclic voltammetry was used to characterise SPE electrodes and electrodes covered 
with APBA polymer. Deposition of polymer is illustrated in Figure 79. The cyclic 
voltammogram of NIP and MIP electrodes, immersed in PB buffer, showed higher 
passage of current than SPEs. Anodic and cathodic peaks were not detectable, neither 
on modified electrodes nor on SPE electrodes. This suggests that the APBA is not a 
very conductive polymer. Also, different types of substrate may have an influence on 
polymer properties. A modified gold electrode did not exhibit an increase in passage of 
current. Previous studies showed that a gold electrode (WE) was more conductive than 
SPE. Therefore electron transfer may be lowered on a gold electrode covered with 
polymer in comparison to the bare gold. Also studies carried out by Rick et al. (2006) 
showed a significant difference in APBA polymer, electropolymerised on gold, 
platinum and platinum coated with polypyrrole. Redox peaks were not detectable on 
gold electrodes.  
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Figure 79. Cyclic voltammetry of SPE and electrodes covered with polymer immersed 
in PB buffer at pH 7.5. The second cycle is shown and the scan rate was 50 mV/s. 
 
 
Figure 80. Cyclic voltammetry performed in PB at pH 7.5 on a SPE, Electrochemical 
cell: Ag/AgCl - RE, Pt-CE, Au-WE or NIP-Au as WE. Second cycle; scan rate  
50 mV/s. 
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The CV of 0.5 mM HQ showed redox peaks at the same potential for SPE and NIP 
electrodes (Table 19, Figure 81) However NIP showed a broadening of the oxidation 
peak starting from a potential of +70 mV. 
 
Table 19. Characterisation of electrodes with HQ (0.5 mM). 
  
  
Epa Epc 
ip 
(forward) 
ip 
(backward) 
mV µA 
SPE 160 -135 20 -19 
NIP 175 -140 18.3 -16.8 
 
 
Figure 81. Cyclic voltammetry of HQ (0.5 mM) in PB buffer at pH 7.5 on electrodes. 
Scan rate 50 mV/s. 
 
The CV of 50 mM HQ showed oxidation peaks at the different potentials for SPE and 
NIP and the same reduction potential. The higher peak separation on SPE can be 
explained by a high concentration of mediator which results in higher IR drop (Pletcher, 
1991). The difference was also noted in anodic and cathodic current for the electrodes. 
A lower current was obtained with the NIP sensor (Table 20, Figure 82). The current 
decrease on the NIP electrode may be due to a larger distance of HQ from the polymer 
layer. The cyclic voltammogram of 50 mM HQ containing H202 (4 mM) and 
haemoglobin (0.3 mg/mL) showed a significant decrease in cathodic current, namely 
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289 µA at a potential -115 mV (Figure 83). Haemoglobin may be in a close proximity to 
the electrode and may decrease the electron transfer. 
 
Table 20. Characterisation of electrodes with HQ (50 mM). 
  
  
Epa Epc ipa ipc 
mV µA 
SPE 400 -85 518 546 
NIP 110 -85 252 482 
 
 
Figure 82. Cyclic voltammetry of HQ (50 mM) in PB buffer at pH 7.5 on SPE-D and 
NIP electrodes. Second cycle; scan rate 50 mV/s. 
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Figure 83. Cyclic voltammetry of HQ in the presence of Hb (0.3 mg/mL) and H202       
(4 mM) in PB at pH 7.5 on NIP electrodes. Second cycle; scan rate 50 mV/s. 
 
Also an electrochemical behaviour of HQ was tested at pH 6.0 on NIP electrodes. The 
cyclic voltammogram of HQ (50 mM) showed a shifted reduction peak at pH 6.0, 
recorded at -160 mV and cathodic current of -362 µA. The first oxidation peak was not 
recorded (Figure 84).  
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Figure 84. Cyclic voltammetry of HQ (50 mM) in PB buffer at pH 6.0 and 7.5 on NIP 
electrodes. Second cycle. Scan rate 50 mV/s. 
 
9.1.2.2 Electrochemical detection of haemoglobin using its peroxidase 
activity 
The chronoamperometric signal was measured at a negative reduction potential of -400 
mV. SPE, NIP and MIP electrodes were used in these experiments. HQ and HbFe
3+
 
stock solutions were prepared in 40 mM phosphate buffer, pH 7.5, with supporting 
electrolyte of 100 mM KCl, unless otherwise stated. Haemoglobin detection was 
performed with 50 mM HQ and 4 mM H202.  
 
Detection of HbFe
3+
 was carried out on SPE and NIP electrodes. Studies were focussed 
on the detection of Hb in the FIA system, which allowed problems with mass transport 
to be avoided and protein binding to be carried out in real time. A linear calibration 
curve was obtained for HbFe
3+
 detection in the FIA system over a range of 0.05 to 2 
mg/mL. Measured samples gave a calibration curve described by the equations showed 
in Table 21 (Figures 85-87). Response of those electrodes for samples without 
haemoglobin was significantly different. Higher current signal was obtained for NIP and 
MIP in comparison to SPE electrodes: 5.05 µA; 8.16 µA and 2.45 µA, respectively. 
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Table 21. Calibration curve for Hb detection. 
NIPs y = 1.54E-05x + 4.00E-6 R2 = 0.9877 
MIPs y = 1.44E-05x + 5.86E-07 R2 = 0.9884 
 
Experiments were carried out with deoxygenated and non-deoxygenated carrier 
solution. Higher background current was recorded with non-deoxygenated carrier 
solution (PB buffer). A larger background current may cause an increase of noise level, 
especially at a higher reduction potential, in the presence of oxygen. However, similar 
detection of HbFe
3+
 was obtained on NIP electrodes experiments with deoxygenated 
and non-deoxygenated PB buffer (Figure 88).  
 
 
Figure 85. Amperometric response of successive injections of sample (50 µL) 
containing HQ (50 mM), H202 (4 mM) and HbFe
3+ 
(from 0 to 2 mg/mL) on NIP.
  
PB deoxygenated (pH 7.5). Flow rate 0.5 mL/min. 
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Figure 86. Amperometric response of successive injections of sample (50 µL) 
containing HQ (50 mM), H202 (4 mM) and HbFe
3+ 
(from 0 to 2 mg/mL) on MIP.  
PB deoxygenated (pH 7.5). Flow rate 0.5 mL/min. 
 
 
Figure 87. Detection of HbFe
3+
 using its peroxidase activity with HQ (50 mM), H202  
(4 mM) in PB at pH 7.5 on NIP and MIP electrodes at a potential -400 mV in the FIA 
system. Carrier solution deoxygenated.  
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Figure 88. Detection of HbFe
3+
 using its peroxidase activity with HQ (50 mM), H202  
(4 mM) in PB at pH 7.5 on NIP electrodes at a potential -400 mV in the FIA system. 
Carrier solution non-deoxygenated. 
 
Further work was focussed on the detection of HbA0 and HbA1c. HbA0 (0.3 mg/mL) 
showed a lower electrochemical signal than HbA1c (0.3 mg/mL): 4.61 µA and 6.01 µA, 
respectively (Figure 89). Lower peroxidase activity of glycated haemoglobin was 
reported by Khoo et al. (1994). However the glycated haemoglobin in presence of 
sorbitol showed higher peroxidase activity. Non-glycated Hb stabilised with sorbitol did 
not exhibit a change in enzymatic activity (Khoo et al., 1994). Potassium cyanide may 
have the same effect on peroxidase activity; it attaches to the heme group and stabilises 
the protein structure. Decreased consumption of H202 in the presence of sodium cyanide 
was demonstrated by Nagababu et al. (2000). Enzymatic activity of HbA0, HbA1c may 
be also dependent on different protein concentration and reaction times. 
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Figure 89. Amperometric response of successive injections of sample (50 µL) 
containing HQ (50 mM), H202 (4 mM) and 0.3 mg/mL HbA0 or HbA1c on SPE.  
PB deoxygenated (pH 7.5). Flow rate 0.5 mL/min. 
 
It was reported in previous studies that APBA is able to recognize HbA1c (Bossi et al., 
2001; Pribyl and Skladal, 2006). It was suggested that the difference in isoelectric point 
may have a positive effect on variation in recognition (Bossi et al., 2001).  
 
Detection of HbA0 and HbA1c was performed on NIP electrodes at pH 6.0; 7.0; 8.0 and 
also at pH 6.0 in buffer containing 0.5 % Tween 20 as a carrier solution. Injected 
samples contained HQ (50 mM), H202 (4 mM) with or without haemoglobin (0.3 
mg/mL). Samples without haemoglobin were injected in triplicate followed by five 
injections of samples containing haemoglobin.  Figure 90 shows haemoglobin detection 
at pH 6.0. At pH 6.0 samples without haemoglobin showed a decrease in current in the 
subsequent injection, the opposite effect was observed at pH 8.0. The current response 
obtained with samples without haemoglobin was subtracted from the current response 
of samples with protein. Results are presented in Table 22. The highest difference in 
signal for HbA1c was obtained at pH 6.0, with or without surfactant. However it is 
necessary to amplify the difference between HbA1c and HbA0 to be able to work with 
lower concentration of HbA1c. 
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Table 22. Influence of pH on NIP sensor  response.   
NIP electrodes HbA0 HbA1c 
Increase 
in signal 
for 
HbA1c 
pH i (µA) stdev i (µA) stdev i (µA) 
6 0.91 0.26 2.48 0.59 2.72 
7 1.56 0.17 3.09 0.24 1.98 
8 2.81 1.19 3.99 1.56 1.42 
6  with Tween20 0.82 0.25 2.33 0.64 2.84 
 
 
Figure 90. Amperometric response of successive injections of sample (50 µL) 
containing HQ (50 mM), H202 (4 mM) and 0.3 mg/mL HbA0 or HbA1c on NIP.  
PB deoxygenated (pH 6.0). Flow rate 0.5 mL/min. 
 
Further work was continued with PB pH 6.0 as a carrier solution on MIP electrodes. A 
significantly different binding of HbA1c and HbA0 on MIPs electrodes was not 
obtained (Table 23). The difference in signal was lower than on NIP electrodes. The Hb 
trapped in polymer matrix might have an influence on the results.   
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Table 23. HbA0, HbA1c binding on MIP electrodes. 
  
HbA0 
 
HbA1c 
 
signal 
increase 
for 
HbA1c 
  i (µA) stdev i (µA) stdev i (µA) 
carrier solution PB pH 6.0      
MIP1c 1.43 0.44 2.57 0.25 1.80 
MIP0 1.53 0.19 2 0.29 1.31 
carrier solution PB pH 6.0 with 
Tween 20      
MIP1c 1.27 0.26 1.44 0.15 1.13 
MIP0 1.62 0.8 2.37 0.59 1.46 
 
A lack of significant binding of haemoglobin on MIP electrodes may be due to a small 
surface area and low binding capacity of polymer. The enzymatic reaction of Hb before 
binding and a short time of binding may have an impact on the results presented. 
Samples were incubated for 20 seconds before injection and stayed on the electrode for 
around one minute. There is also a possibility that HQ blocked specific binding sites. 
Stabilisation of Hb may have a negative influence on a rebinding detection, especially if 
Hb is detected over a short time. High background current (sample without Hb) on 
electrodes covered with polymer and electrostatic forces could have a negative effect on 
the recognition process as well. 
9.2 Spectrophotometric analysis of haemoglobin binding 
NIP and MIP polymers were grafted on a surface of microplates and tested 
spectrophotometrically to verify an impact of possible problems related to 
electrochemical detection described in the previous chapter.  
9.2.1 Materials and methods 
9.2.1.1 Reagents 
Sodium monobasic phosphate (CAS No: 7558-80-7), sodium dibasic phosphate (CAS 
No: 7558-79-4), sodium hydroxide (CAS No: 1310-73-2), phosphate – citrate buffer 
tablet, APBA (CAS No: 206658-89-1), ammonium persulfate (CAS No: 7727-54-0) 
ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt, (CAS 
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No: 30931-67-0), TMB (CAS No: 64285-73-0), were purchased from Sigma-Aldrich 
(Dorset, UK),  glycated haemoglobin (HbA1c) and non-glycated haemoglobin (HbA0) 
were purchased from Exocell, Inc. (Philadelphia, USA). Chemicals were used as 
received. 
9.2.1.2 Apparatus 
The following other equipment was used in experiments: centrifuge, Jouan B4i was 
purchased from Thermo Fisher Scientific (Waltham, USA); spectrophotometer, 
Shimadzu 1800 (Shimadzu, Kyoto, Japan); microplate reader, Varioscan Flash version 
2.4.3 was purchased from Thermo Fisher Scientific (Hampshire, UK); Microplate 
Immuno MaxiSorp 96 well flat bottom polystyrene was purchased from Fisher 
Scientific Ltd. (Loughborough, UK); pH-meter, Hanna Instruments 8519 was purchased 
from Hanna Instruments Inc. (Woonsocket, USA); Amicon ultra-15 and ultra-4 
centrifuge filter (30kDa cut-off) was provided by Millipore Ltd. (Watford, UK);  
9.2.1.3 Haemoglobin isolation from human blood 
Isolation and purification of haemoglobin was performed at 20
o
C. 2 mL of human blood 
was mixed with 6 mL of NaCl (0.9%). Solution was centrifugated for 10 minutes at 
1620 g. Supernatant (plasma) was discarded and the washing procedure with NaCl 
repeated three times. Red blood cells (RBCs) were collected, mixed with 11 mL of 
distilled water and left for 10 minutes for hemolysis. Solution was centrifugated for 40 
minutes at 2880g. Clear, red supernatant containing haemoglobin was collected. The 
content of Hb was determined by Drabkin’s method. Haemoglobin was purified by 
passing over the PD-10 column packed with Sephadex G-25 fine. 1 mL of Hb (10 
mg/mL) sample was loaded on the column and eluted with PB buffer (50 mM) at pH 
7.5. Then haemoglobin was concentrated on the amicon ultra-4 centrifugal filter unit 30 
kDa cut-off. Firstly the filter unit was rinsed with dH20 to remove trace amounts of 
triethylene glycol and then was filled with 4 mL of the sample. Hb solution was 
centrifugated 10 minutes at 2880 g. The content of Hb was determined by Drabkin’s 
method. 
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9.2.1.4 Spectrophotometric determination of Hb by Drabkin's method 
Drabkin’s solution was prepared by reconstitution of one vial of Drabkin’s Reagent with 
1000 mL of water. Then 0.5 ml of the 30% Brij 35 solution was added. The prepared 
Drabkin’s solution was kept at room temperature 22 oC, protected from light. 
Cyanmethemoglobin standard solution was prepared. It contained 50 mg/mL of human 
haemoglobin (Hb purchased from Sigma, containing mainly HbFe
3+) in Drabkin’s 
solution. Working standard solutions were prepared. Standards were serially diluted in 
Drabkin’s solution (2-fold dilution). 25 µL per well of standard solution, unknown Hb 
sample or Drabkin’s reagent were pipetted on a microplate. 200 µL of Drabkin’s 
reagent was added per well, plate was shaked and left for 40 min at room temperature 
(+22 °C). Absorbance was read at 540 nm on a microplate reader and calibration curve 
of absorbance value versus cyanmethemoglobin concentration was plotted. Total 
haemoglobin concentration (mg/mL) of each test was determined from the calibration 
curve. 
9.2.1.5 Detection of haemoglobin from different sources with ABTS-P 
Enzymatic activity of Hb was carried out with ABTS or TMB substrate for ELISA 
assay. ABTS and TMB substrates were brought to room temperature before use. All 
measurements were made in triplicate. 
 
HbA0 and HbA1c in storage buffer 1 mM KCN, pH 7.4; HbFe
3+
 lyophilized form and 
HbFe
2+
 isolated from blood were tested. An aliquot (10 µL) of Hb (dH20) was pipetted 
to the well of a microplate and 90 µL solution of ABTS or TMB per well was added. 
The ABTS mixture contained 6.7 mg ABTS and 3.3 µL H202 (30%, w/w) in 10 mL 
citrate buffer (0.1 M, pH 6.0). The TMB solution comprised a TMB tablet dissolved in 
10 mL phosphate-citrate buffer containing H202. Phosphate–citrate buffer was prepared 
by dissolving one tablet in 100 mL dH20.  Absorbance was measured after 10 minutes, 
30 minutes and 2 hours at a wavelength of 405 nm for ABTS and of 655 nm for TMB. 
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9.2.1.6 Preparation of polymer on microplates for recognition HbA0 and 
HbA1c 
Microplates were coated with a polymer layer (NIP) by chemical polymerisation of 
APBA by means of oxidation with ammonium persulfate. 50 µL of APBA (100 mM) 
was placed on microplates by single channel pipette and 50 µL of ammonium persulfate 
(50 mM) was added by multichannel pipette. Polymerisation was carried out 30 minutes 
at room temperature. Then microplates were washed 2 times with dH20 and 7 times with 
a washing buffer (3% acetic acid, containing 0.1% Tween 20) to remove a template. 200 
µL of the buffer was put per well by multichannel pipette. Plate was shaken and 
solution poured out. Plates were conditioned 30 minutes in 50 mM sodium phosphate 
buffer, containing 0.1% Tween 20. Microplates were left at room temperature and used 
the same day. 
 
Microplates were also coated with molecularly imprinted polymer. 50 µL of APBA / Hb 
solution was placed per well and 50 µL ammonium persulfate (50 mM) was added. 
Haemoglobin was dissolved in APBA solution. Concentration of template (Hb) was 0.5 
mg/mL and molar ratio APBA: ammonium persulfate was 2:1. Polymerisation, washing 
step and conditioning of microplates were performed as described above for NIP 
microplates. 
9.2.1.7 Rebinding of HbA0, HbA1c on microplates coated with APBA 
polymer  
100 µL of haemoglobin in concentration 1; 3; 5; 10; 30; 50; 100 µg/mL was pipetted per 
well. Haemoglobin was prepared in 50 mM sodium phosphate buffer, containing 0.1% 
Tween 20, pH 7.0. Rebinding of Hb lasted for 90 minutes and then microplates were 
washed in sodium phosphate buffer (50 mM) containing 0.1% Tween 20, pH 7.0. 200 
µL of solution was pipetted per well, plate was shaken and the solution poured out. 
9.2.1.8 Detection of rebound haemoglobin 
Rebound haemoglobin was detected with ABTS ready to use substrate. 100 µL solution 
of ABTS was pipetted per well. Absorbance was measured at 405 nm after 10 minutes, 
30 minutes, and 2 hours. Also 50 µL of the solution was transferred to the new plate 
after 2 hours and absorbance was measured at 405 nm. Background (0 µg/mL of 
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rebound Hb) which was recorded for NIP, MIP-A0 and MIP-A1c was subtracted from a 
signal response resulting from rebound Hb (1-100 µg/mL). The dissociation constant 
(Kd) was calculated from the Scatchard–Rosenthal equation: Bmax/B = Kd 1/C + 1, 
where B refers to a bound sites, C is a concentration of proteins. 
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9.2.2 Results and Discussion 
9.2.2.1 Detection of haemoglobin from different sources with ABTS-P 
Enzymatic activity of commercially available haemoglobin was tested to verify the 
influence of different Hb preparations. HbA0 and HbA1c in 1mM KCN solution, 
HbFe
3+
 lyophilised and HbFe
2+
 isolated from blood were studied. Haemoglobin was 
detected in the range 1 to 30 µg/mL. HbA0 (10 µg/mL) showed the lowest signal after 
10 minutes incubation with ABTS-P, but after 2 hours the response was higher in 
comparison to the other proteins (Figures 91-94). 
 
 
Figure 91. Hb detection on microplates with ABTS-P. Reaction time 10 minutes. 
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Figure 92. Calibration curve for Hb detection on microplates with ABTS-P. Reaction 
time 10 minutes. 
 
 
Figure 93. Hb detection on microplates with ABTS-P. Reaction time 2 hours. 
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Figure 94. Calibration curve for Hb detection on microplates with ABTS-P. Reaction 
time 2 hours. 
 
9.2.2.2 Detection of HbA0 with different substrates for ELISA assays 
Different substrates for an ELISA assay were tested to choose the compound with the 
highest sensitivity. The reactivity of ready-to-use ABTS was studied with a chemical 
enhancer to improve assay sensitivity. The reaction was recorded after 10 minutes, 30 
minutes and 2 hours at 405 nm for ABTS and 655 nm for TMB substrate. The best 
response was obtained with ready-to-use ABTS. Hb was detected in the range 0.1 to 30 
µg/mL.   
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Figure 95. HbA0 detection on microplates with different ELISA substrates. Reaction 
time 10 minutes. 
 
 
Figure 96. Calibration curve for HbA0 detection on microplates with different ELISA 
substrates. Reaction time 10 minutes. 
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Figure 97. HbA0 detection on microplates with different ELISA substrates. Reaction 
time 2 hours. 
 
 
Figure 98. Calibration curve for HbA0 detection on microplates with different ELISA 
substrates. Reaction time 2 hours. 
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9.2.2.3 Rebinding of HbA0, HbA1c on microplates coated with APBA 
polymer 
HbA0 and HbA1c binding on the NIP/MIP was studied using the protocols previously 
developed at Cranfield University (Bossi et al., 2001). Rebinding of Hb was studied in a 
different range, from 1 to 100 µg/mL. Ready-to-use ABTS was chosen to detect Hb 
bound to the polymer. Rebinding of Hb on NIP polymer was insignificant. The 
dissociation constant for rebinding of HbA1c on the MIP-A1c and HbA0 on the MIP-
A0 was around 30 – 40 nM. However, rebinding of HbA1c on the MIP-A0 and HbA0 
on the MIP-A1c was in the same range, 30 – 40 nM.  
 
 
Figure 99. Rebinding of HbA0. Detection with ABTS ready to use. Absorbance read on 
the same microplate after 2 hours reaction. 
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Figure 100. Rebinding of HbA1c. Detection with ABTS ready to use. Absorbance read 
on the same microplate after 2 hours reaction.  
 
To improve detection of Hb, ABTS solution was transferred to the new plate after 2 
hours incubation. A significant difference between results with NIP and MIP was 
obtained (Figure 101). The Kd for HbA0 rebinded on MIP-A0 was 100 nM. 
Insignificant binding was detected on NIP polymer for 30 and 50 µg/mL Hb.  
 
Presented research showed binding of HbA1c on MIP-A1c, MIP-A0 and HbA0 on MIP-
A0 and MIP-A1c. Previously publish work (Bossi et al., 2001) also showed binding of 
HbA1c on MIP-A0. The same effect was observed on MIP-A1c, where both 
haemoglobins, HbA1c and HbA0 were bound. Probably lack of specificity is caused by 
similar structure of HbA1c and HbA0. Differences in binding of HbA1c on MIP-A1c 
compared to previous work (Bossi et al., 2001) may be due to different haemoglobins 
and chemicals which were used for polymer preparation.  
 
 133 
 
 
Figure 101. Rebinding of HbA0. Detection with ABTS ready to use. 50 µL solution was 
transfered to the new microplate after 2 hours and absorbance read at 405 nm.  
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9.2.3 Conclusions 
Stabilised and non-stabilised haemoglobin can be detected using its peroxidase activity. 
Haemoglobin stabilised in KCN has lower peroxidase activity over the shorter reaction 
time in comparison to non-stabilised Hb. HbA1c stabilised in KCN has higher 
peroxidase activity than HbA0 if the enzymatic reaction is carried out over a shorter 
time. Therefore, response of HbA1c sensor should be validated with haemoglobin 
without stabilisers. 
 
There was an enhancement of the binding of Hb to MIP as compared to NIP, which 
indicates presence of an imprinting effect. There is also an indication that MIP binds 
glycated haemoglobin (HbA1c) better compared with non-glycated haemoglobin 
(HbA0). This effect however varies and at the moment it can be concluded that the 
imprinted polymer recognises whole haemoglobin but does not clearly distinguish the 
glycated part of the protein. Further efforts are required to develop a chromatographic 
MIP medium to enhance surface area. However, the process of preparing MIP is likely 
to be unprofitable due to high cost of HbA1c and the amount required for use as a 
template. Furthermore, recognition of HbA1c on MIP-A1c and HbA0 on MIP-A0 may 
be not specific enough to conduct measurements in blood samples. Possible difficulties 
in using MIP technology result from a non-specific binding of HbA0 on MIP-A1c and 
HbA1c on MIP-A0. It may be problematic to determine level of HbA1c in blood 
specimen particularly if HbA1c is present in diabetic and non-diabetic patients. 
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Chapter 10:  Separation of GHb from non-glycated Hb by affinity 
chromatography 
Affinity materials, which were previously used for binding of total glycated 
haemoglobin (GHb), were studied in combination with electrochemical detection of Hb. 
The purpose of this chapter was to determine HbA1c in blood samples which could 
potentially lead to construction of a novel device for HbA1c measurement. 
10.1 Materials and methods 
10.1.1 Reagents 
HQ (hydroquinone with CAS No: 123-31-9), hydrogen peroxide 30% (CAS No: 7722-
84-1), sodium monobasic phosphate (CAS No: 7558-80-7), sodium dibasic phosphate 
(CAS No: 7558-79-4), potassium chloride (CAS No: 7447-40-7), sodium chloride (CAS 
No: 7647-14-5), magnesium chloride (CAS No: 7786-30-3), sodium hydroxide (CAS 
No: 1310-73-2), HEPES (CAS No: 7365-45-9), phosphate buffer saline tablet, 
phosphate – citrate buffer tablet, Drabkin’s Reagent, 30% Brij 35 solution (9002-92-0), 
m-aminophenylboronic acid – agarose (aqueous suspension) were purchased from 
Sigma-Aldrich, product number A8312 (Dorset, UK), glycated haemoglobin (HbA1c) 
was purchased from Scipac (Sittingbourne, UK). Glyco-Tek Affinity Column Kit and 
control samples for HbA1c: Normal and Abnormal level were purchased from Helena 
BioSciences Europe, ClinChek Control (Whole Blood Diabetes Control lyophilised), 
Level I and II were provided by KBWingrove Ltd. (Northampton, UK). Human blood 
was collected into tubes containing EDTA as an anticoagulant. Human blood was kept 
at 4
o
C and used within two weeks. Chemicals were used as received. 
10.1.2 Apparatus 
All electrochemical experiments were performed with the Uniscan potentiostat - 
galvanostat instrument PG580 with UiEChem software (Buxton, UK). Screen Printed 
Electrodes (SPE-D) were purchased from DropSens Ltd. (Oviedo, Spain). Electrodes 
were described in Chapter 6.1.2. 
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The following other equipment was used in experiments: Flow-Cell for screen-printed 
electrodes (wall-jet type) from DropSens (Oviedo, Spain); injector Valve V-7 was 
purchased from GE Healthcare (Amersham, UK); centrifuge, Jouan B4i was purchased 
from Thermo Fisher Scientific (Waltham, USA); spectrophotometer, Shimadzu 1800 
(Shimadzu, Kyoto, Japan); microplate reader, Varioscan Flash version 2.4.3 was 
purchased from Thermo Fisher Scientific (Hampshire, UK); Microplate Immuno 
MaxiSorp 96 well flat bottom polystyrene was purchased from Fisher Scientific Ltd. 
(Loughborough, UK); pH-meter, Hanna Instruments 8519 was purchased from Hanna 
Instruments Inc. (Woonsocket, USA); Amicon ultra-15 and ultra-4 centrifuge filter 
(30kDa cut-off) was provided by Millipore Ltd. (Watford, UK); Slide-A-Lyzer Dialysis 
Cassettes, 10K MWCO, 0.1 - 0.5 ml capacity were purchased from Thermo Fisher 
Scientific Inc. (Rockford, USA); column assembly 3mm dia x 100mm long, End Piece 
Fixed with 25um PTFE Frit; 3-way single key valve were purchased from Omnifit Ltd. 
(Cambridge, UK), mixing Tee-Valve, multisyringe pump (two syringes), syringe pump 
KDS 100 CE Model from KD Scientific Inc. (Holliston, USA), syringe pump Cat 78-
9100C, Cole Palmer Instruments Corporation (Illinois, USA), syringe 60 mL BD 
Plastipak (Drogheda, Ireland). 
10.1.3 Separation of GHb from non-glycated Hb by affinity 
chromatography combined with spectrophotometric detection 
m-Aminophenylboronic acid agarose gel was tested as an affinity material for binding 
total glycated haemoglobin (GHb). 0.5 mL of agarose was transfered to 1 mL catridge 
and equilibrated with 5 mL of a binding buffer containing HEPES (0.1 M) and MgCl2 
(0.05 M) at pH 8.0. 150 µL HbA0 (3.4 mg/mL) was placed on the column and eluted 
without an incubation step. HbA0 was eluted with 20 mL of binding buffer and further 
elution was perform with 3 mL of HEPES buffer (0.1 M) containing sorbitol (0.1 M), 
pH 8.0. 1 mL fractions were collected. The same concentration of HbA0 was also 
analysed on Helena Glyco-Tek Affinity Column with a binding buffer containing 
HEPES (0.1 M) and MgCl2 (0.05 M) at pH 8.0. 
 
HbA0, blood samples, Helena Normal and Abnormal Controls, ClinCheck Controls, 
level I and level II were analysed on Helena Glyco-Tek Affinity Column Kit. The 
 137 
 
HbA1c and GHb values and method of analysis of control samples are shown in the 
Table 24. Data were provided by the producer. HbA1c value of ClinCheck controls of 
the different methods is attached in Appendix 3. 
 
Table 24. Content of HbA1c and GHb (%) in control samples. Data provided by the 
producer. 
 
Helena Lab controls ClinCheck controls 
Method of Analysis 
Helena Glyco-Tek 
Affinity Column 
Method 
RECIPE 
(HPLC) 
Bayer /Siemens 
(immunologic) 
Level 
Normal Abnormal I II I II 
%GHb 
Mean 5.7 18.8 
 
Range 4.7-6.7 17.3-20.3 
%HbA1c 
Mean 
 
4.8 8.7 5.7 10 
Range 4.3-5.3 7.9-9.5 5.2-6.2 9.2-10.8 
 
Catridges contained cellulose resin with covalently bound dihydroxyboryl groups and 
were saturated with a preservative solution containing sodium azide (0.1 %). Control or 
blood samples were incubated for 10 minutes in a hemolysate reagent in the ratio 1:9. 
The hemolysate reagent comprised glycine (0.1 M), MgCl2 (0.05 M), Triton X-100 
(2%) and sodium azide. The column was shaken twice to resuspend the resin adhered to 
the top closure, and solution was eluted until matrix was settled to a level 1.1 cm. The 
rest of the liquid was removed to the top of the resin bed. The column was equilibrated 
with 3 mL of a Glyco-Tek Developer A containing glycine (0.1 M), MgCl2 (0.05 M), 
and sodium azide, pH 8.1-8.6. 100 uL of hemolysate sample was placed on the column 
and left for 8 minutes. Non-glycated haemoglobin was eluted with 4.5 mL of the 
Developer A. Total glycated haemoglobin was eluted with 3 mL of the Developer B, 
buffer containing sorbitol and sodium azide (0.1 %), pH 8.0.  Non-glycated Hb solution 
was diluted with dH20 (10.4 mL).  
 
Separation of GHb from non-glycated Hb was also studied with different buffers. 
Control and blood samples were hemolysed in HEPES (0.1 M) buffer containing MgCl2 
(0.05 M) and Triton X100 (1%), pH 8.0 in the ratio 1:9. Samples were hemolysed for 10 
minutes. The Glyco-Tek Affinity Column was equlibrated with 3 mL of a binding 
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buffer containing HEPES (0.1 M) and MgCl2 (0.05 M) at pH 8.0. 100 µL of the 
hemolysate sample was placed on the column and incubated for 8 minutes. Non-
glycated haemoglobin was eluted with 4.5 mL of a binding buffer, firstly 0.5 mL buffer 
was placed on the column. Total glycated haemoglobin (GHb) was eluted with 3 mL of 
HEPES buffer (0.1 M) containing sorbitol (0.1 M), pH 8.0. Separation of GHb was also 
performed on the Omnifit glass column packed with affinity matrix (ID 3 mm; volume 
0.701 mL). The bottom of the column was connected to the end piece fixed with 25 um 
PE frit. Sleeve (3 mL) was connected with the column and filled with a matrix. The 
column was packed with an aqueous solution of Glyco-Tek affinity matrix previously 
degassed. The column was packed in the flow of buffer. Once the slurry was settled, the 
column was connected to the pump with flow rate adjusted to 0.14 mL/min. The column 
was again completely filled up with the matrix and connected to the injector. The 
column was equilibrated with 7 mL of degassed binding buffer: HEPES (0.1 M) 
containing MgCl2 (0.05 M) at pH 8.0 at the flow rate adjusted to 0.14 mL/min during 
equilibration of the column. ClinCheck control sample, level I was analysed. The flow 
rate was adjusted to 0.07 mL/min and 50 uL of the hemolysate was injected on the 
column. Non-glycated Hb solution was diluted with dH20 (10.4 mL).  
 
Absorbance was read at 415 nm for GHb and non-glycated Hb solution immediately. 
The content of GHb (%) was calculated. Percentage of HbA1c was calculated according 
the algorithm: HbA1c = 0.6846 x %GHb + 0.973258 
10.1.4 Effect of buffer composition on electrochemical response of HQ 
and Hb detection on SPE 
Cyclic voltammetry was used for the qualitative characterisation of redox behaviour of 
HQ in different buffer solutions. Three cycles were performed for each electrode at a 
scan rate 50 mV/s. Voltammograms were run from negative toward positive potentials. 
 
Glycine buffer (pH8.6), HEPES and phosphate buffer (PB) at pH 8.0 were studied. 
HEPES buffer consisted of HEPES (100 mM), MgCl2 (50 mM); Glycine buffer 
consisted of glycine (100 mM), MgCl2 (50 mM); PB consisted of sodium monobasic 
phosphate and sodium dibasic phosphate (100 mM). Electrodes were immersed in a 
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vertical position in a 10 mL beaker containing 5 mL of HQ solution and 5 mL of a 
tested buffer. HQ stock solutions (100 mM) used for electrochemical analysis were 
prepared daily in a deoxygenated solution of KCl (200 mM). Mediator was prepared in 
a solution deoxygenated by purging with nitrogen. Additionally mediator stock solution 
was deoxygenated by blowing nitrogen over the solution for 5 minutes. Mediator was 
kept in 4
o
C during measurements. CV was performed under unstirred conditions. 
 
The same buffers were used to plot a calibration curve for Hb detection by a 
chronoamperometric method. Samples consisted of HQ (50 mM), H202 (4 mM) and 
haemoglobin. 100 µL of the solution under study was placed on the electrode. Samples 
comprised 50 µL of the HQ/H202 solution and 50 µL of the studied buffer. Experiments 
were performed on SPE-D electrodes at room temperature 22
o
C. Measurements were 
performed in triplicate. Data were processed in Microsoft Office Excel and average 
values calculated.  
10.1.5 Separation of GHb from non-glycated Hb by affinity 
chromatography combined with electrochemical detection 
Total glycated haemoglobin (GHb) was separated from non-glycated haemoglobin on 
the Glyco-Tek Affinity Column. It contained cellulose matrix with covalently bound 
dihydroxyboryl group. Blood samples, Helena Normal and Abnormal Controls, 
ClinCheck Controls, level I and level II were analysed. Haemoglobin concentration in 
control and blood samples was determined by Drabkin’s method described in Chapter 
9.2.1.4. Blood samples were hemolysed in HEPES (0.1 M) buffer containing MgCl2 
(0.05 M) and Triton X100 (1%), pH 8.0 in the ratio 1:9. The samples were hemolysed 
for 10 minutes. The affinity column was shaken twice to resuspend the resin adhered to 
the top closure, and solution was eluted until matrix was settled to a level 1.1 cm. The 
rest of the liquid was removed to the top of the resin bed. The column was equlibrated 
with 3 mL of a binding buffer:  HEPES (0.1 M) containing MgCl2 (0.05 M) at pH 8.0. 
100 µL of hemolysate sample was placed on the column and left for 8 minutes. Non-
glycated haemoglobin was eluted with 4.5 mL of binding buffer. Total glycated 
haemoglobin was eluted with 3 mL of HEPES buffer (0.1 M) containing sorbitol (0.1 
M), pH 8.0.  
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Chronoamperometry was used to analyse eluted samples on SPE-D electrodes at a 
reduction potential of -400 mV. Measured samples comprised 50 µL of the HQ/H202 
solution and 50 µL of eluted haemoglobin. Samples contained HQ (50 mM), H202 (4 
mM) and eluted non-glycated Hb or GHb. 100 µL of the solution under study was 
incubated 20 seconds then placed on the SPE electrode and the amperometric signal was 
recorded over 500 seconds. HQ and H202 stock solutions were prepared in a 
deoxygenated solution of KCl (200 mM) daily. Solutions were deoxygenated by 
purging with nitrogen. Additionally mediator stock solution was deoxygenated by 
blowing nitrogen over the solution for 5 minutes. Mediator was kept in room 
temperature (22
o
C) during measurements. Experiments were performed on SPE-D 
electrodes at room temperature. Measurements were performed in triplicate. Data were 
processed in Microsoft Office Excel and average values calculated. The content of GHb 
and non-glycated Hb was read from the calibration curve and GHb (%) calculated. GHb 
(%) was also determined directly from the values of current signal for GHb, non-
glycated Hb and total Hb.  
 
Separation of GHb was also performed on the Omnifit glass column which was packed 
with affinity material (ID 3 mm; volume 0.701 mL). Column was prepared in the same 
manner as previously described in Chapter 10.1.3. HQ (200 mM) and H202 (16 mM) 
were pumped in a separated stream with a multisyring pump. Substrates were mixed in 
the Micro Static Mixing Tee and further mixed in the PTFE tube (I.D. 0.8 mm, length 
54 cm), at a combined flow rate 0.07 mL/min. Omnifit Column (I.D. 3 mm; volume 
0.701 mL) was connected to the injector (Valve V-7, loop 50 uL) with PTFE tube (I.D. 
0.8 mm, length 13.5 cm). The bottom of the column was connected to the PTFE tube 
(I.D. 0.8 mm, length 13.5 cm). HQ/H202 substrates were mixed with a stream passing 
through the affinity column, in the second Micro Static Mixing Tee and further mixed in 
the PTFE tube (I.D. 0.8 mm, length 54 cm) which was connected to the flow cell. Either 
the binding buffer or the elution buffer was run through the injector and the column. For 
that purpose two syringe pumps were used. PTFE tubes from the syringes (I.D. 0.8 mm, 
length 27 cm) were connected with a stream changing valve. The flow rate was adjusted 
to 0.07 mL/min through the column. Chronoamperometry was used to determine the 
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content of non-glycated Hb and GHb in the sample. Eluted fractions of haemoglobin 
were detected on SPE-D electrodes at a potential -400 mV.  
 
Percentage of HbA1c was calculated according the algorithm: HbA1c = 0.6846 x 
%GHb + 0.973258 
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10.2 Results and Discussion 
10.2.1 Spectrophotometric detection of haemoglobin 
m-Aminophenylboronic acid agarose was tested as an affinity material for HbA1c 
determination. Non-specific binding was observed for HbA0 since only 43.5 % and 59 
% of total HbA0 was eluted with 10 and 20 mL of binding buffer, respectively. These 
results suggest a poor quality of the affinity material. It is possible that pores were too 
small for haemoglobin to enter. Polysaccharide chains of agarose that consist of 
galactose units, without covalent cross-linking can lead to shrinkage and lower stability 
of the matrix. The procedure of preparation and factors, such as amount of stabiliser, 
stirrer speed and storage condition may lead to damage of agarose beads (Dean et al., 
1985). An activation process of matrix has also an impact on non-specific binding 
caused by ion-exchange interferences (Mallia et al., 1981). Elution of HbA0 was also 
verified on Helena Glyco-Tek Affinity Column Kit and 96 % of haemoglobin was 
recovered. Therefore this affinity resin was used for further research. 
 
Analysis of blood samples was performed on Helena Glyco-Tek Affinity Column Kit. 
Catridges contained cellulose resin with covalently bound dihydroxyboryl groups. 
HEPES buffer was tested with Glyco-Tek and Omnifit column containing the same 
affinity resin. Control samples containing normal, abnormal level of total glycated 
haemoglobin (GHb) and blood samples were analysed. Results are summarized in Table 
25. 
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Table 25. Content of HbA1c and GHb (%) in control samples. 
APBA cellulose 
  
  
  
  
Catridges – commercial kit 
Catridges  
HEPES buffer 
Omnifit 
Column  
HEPES 
buffer 
Diabetes Controls Blood 
 
Diabetes Controls 
Helena ClinCheck ClinCheck 
Normal Abnormal I II  I II I 
% 
GHb 
4.9 17.2 7.5 12.1 4.6 6.7 10.1 6 
% 
HA1c 
4.3 12.7 6.1 9.3 4.1 5.6 7.9 5.1 
 
Percentage of HbA1c was comparable with data provided by the producer of control 
samples. Small differences between results obtained with HEPES buffer and glycine 
buffer (Catridges – commercial kit) could be due to the lower pH of HEPES buffer (pH 
8.0) or because of some variation between columns. Blood samples contained lower 
concentration of HbA1c compared to controls with normal level of HbA1c.  
10.2.2 Electrochemical detection of haemoglobin 
10.2.2.1 Effect of buffer composition on electrochemical response of HQ 
and Hb detection SPE 
Measurements were performed in HEPES, phosphate (pH 8.0) or glycine buffer (pH 
8.6). All measured samples contained HQ (50 mM).  
 
Cyclic voltammetry was used to obtain fast information about the redox behaviour of 
HQ in different buffer formulations. Similar voltammograms of HQ were recorded on 
SPE-D electrodes (Figures 102, 103 and 104). Three reduction peaks were recorded for 
phosphate and HEPES buffer but two peaks were obtained with glycine buffer. The 
difference may be caused by different pH of buffer since the mediator is pH dependent. 
The cyclic voltammogram of HQ in HEPES buffer was shifted towards more negative 
potentials. Third reduction peak was recorded at a negative potential of -240 mV. 
Summary of the cyclic voltammograms is shown in the Table 26. 
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Table 26. Effect of buffer composition on electrochemical response of HQ (50 mM) on 
SPE-D electrodes. 
  
  
Epc ip (reverse peak) 
mV µA 
buffer/peak 1 2 3 1 2 3 
HEPES 110 -115 -240 -170 -440 -490 
Glycine 110 -85   -494 -382   
Phosphate 215 -25 -135 -132 -393 -448 
 
 
Figure 102. Cyclic voltammetry of HQ (50 mM) in HEPES buffer at pH 8.0 on SPE-D 
electrodes. Second cycle; scan rate 50 mV/s. 
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Figure 103. Cyclic voltammetry of HQ (50 mM) in glycine buffer at pH 8.6 on SPE-D 
electrodes. Second cycle; scan rate 50 mV/s. 
 
 
Figure 104. Cyclic voltammetry of HQ (50 mM) in phosphate buffer at pH 8.0 on SPE-
D electrodes. Second cycle; scan rate 50 mV/s. 
 
The chronoamperometric signal was measured at a reduction potential of -400 mV. 
Haemoglobin detection was performed with HQ (50 mM) and H202 (4 mM). HEPES, 
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phosphate and glycine buffer were tested (Figures 105-107). HEPES and glycine buffer 
are well recognized in separation of glycated haemoglobin from non-glycated one. 
 
100 µL of the solution under study was incubated 20 seconds, placed on the SPE-D 
electrode and the amperometric signal was recorded. The lowest detection limit (0.008 
mg/mL Hb) was obtained with HEPES buffer at 500 seconds (Figures 107-108). 
Increased incubation time to 1 and 5 minutes, prior to electrochemical detection, did not 
improve a detection limit. A calibration curve for detection of Hb was not obtained in 
glycine buffer. A higher current signal was obtained with blank samples. Measurements 
with Hb solution did not show a significantly different response (Figure 106). 
 
 
Figure 105. Amerometric response for different concentration of Hb (from 0 to 0.13 
mg/mL) in phosphate buffer, pH 8.0 on SPE-D at a potential -400 mV. Sample 
contained ClinCheck Control (level I), HQ (50 mM) and H202 (4 mM).  
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Figure 106. Amerometric response for different concentration of Hb (from 0 to 0.13 
mg/mL) in glycine buffer, pH 8.6 on SPE-D at a potential -400 mV. Sample contained 
ClinCheck Control (level I), HQ (50 mM) and H202 (4 mM).  
 
 
Figure 107. Amerometric response for different concentration of Hb (from 0 to 0.25 
mg/mL) in HEPES buffer, pH 8.0 on SPE-D at a potential -400 mV. Sample contained 
ClinCheck Control (level I), HQ (50 mM) and H202 (4 mM). 
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Figure 108. Detection of Hb (ClinCheck Control, level I) using its peroxidase activity 
with HQ (50 mM), H202 (4 mM) in HEPES buffer, pH 8.0 on SPE-D at a potential  
-400 mV.  
 
10.2.2.2 Separation of GHb from non-glycated Hb by affinity 
chromatography – catridge setup 
The chronoamperometric signal was measured at a negative reduction potential of -400 
mV. Haemoglobin detection was performed with HQ (50 mM) and H202 (4 mM) on 
SPE-D electrodes.  HEPES buffer was used for total Hb detection.  
 
Table 27 shows the content of GHb and non-glycated Hb in control samples. The 
concentration of measured samples on the electrode was calculated on the basis of total 
Hb concentration (determined by Drabkin’s method) and HbA1c (%) provided by the 
producer. The concentration of GHb and non-glycated Hb was in a detection range after 
elution from the column and dilution on the electrode (Figures 107-108). 
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Table 27. Concentration of non-glycated Hb and GHb in control samples based on data 
provided by the producer 
  
ClinCheck Controls 
 
Glyco-Tek Controls 
Level I Level II Normal Abnormal 
Hb concentration in the sample 
GHb % 5.6 11.3 5.7 18.8 
HbA1c  % 4.8 8.7 4.9 13.8 
HbA1c  mg/mL 6.96 12.69 8.13 22.23 
GHb  
mg/mL 
8.10 16.47 9.51 30.19 
non-glycated Hb  136.83 129.43 157.34 130.41 
Total Hb  144.93 145.9 166.85 160.6 
Hb concentration on SPE 
GHb  
mg/mL 
0.015 0.030 0.018 0.056 
non-glycated Hb  0.165 0.156 0.190 0.157 
Total Hb  0.175 0.176 0.202 0.194 
 
ClinCheck control samples, level I and II were analysed. Total glycated haemoglobin 
(GHb) was separated on the column containing the cellulose resin with covalently 
bound dihydroxyboryl group. The concentration of non-glycated and total glycated 
haemoglobin after elution from the column was determined electrochemically. The total 
content of Hb was determined without passing a sample through the column and was 
also calculated from the signal of the eluted samples, non-glycated and glycated 
fractions. Percentage of HbA1c was determined on the basis of amperometric response 
of total Hb, GHb and non-glycated Hb recorded at 500 seconds (Figures 109-110). The 
concentration of Hb was also calculated from the calibration curve that was prepared for 
ClinCheck Control, level I.  Data were analysed at 500 seconds (Figure 108) and 
percentage of HbA1c was calculated. Analysis of electrochemical data of non-glycated 
Hb and GHb is shown in the Tables 27, 28 and 29. GHb (%) was determined from the 
calibration curve and HbA1c (%) calculated. Also analysis of electrochemical signal of 
GHb and non-glycated Hb gave similar results. Analysis of control sample, level II 
showed percentage of HbA1c similar to data provided by producer (around 10 %, Table 
28). However, the same percentage of HbA1c was obtained for the control sample,  
level I. Analysis of samples from a second affinity column showed the increased content 
of HbA1c. In that case the difference between controls, level I and II was around 2% 
(non-glycated Hb and GHb fractions, Table 29). It was possible to detect GHb and non-
glycated Hb in normal and elevated level of HbA1c in control samples, but it was 
problematic to detect small difference between normal and abnormal levels of HbA1c. 
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The problem with repeatability was observed at 500 seconds (Figures 109, 110). The 
same measurements were analysed at shorter time (50 seconds). The current signal 
showed decreased relative standard deviation but GHb was not detected at 50 seconds 
(Figures 111, 112).  
 
 
Figure 109. Electrochemical determination of non-glycated Hb and GHb after elution 
from column 1. Data analysis after 500 seconds. A background current was subtracted 
from a signal current. 
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Figure 110. Electrochemical determination of non-glycated Hb and GHb after elution 
from column 2. Data analysis after 500 seconds. A background current was subtracted 
from a signal current. 
 
 
Figure 111. Electrochemical determination of non-glycated Hb and GHb after elution 
from column 1. Data analysis after 50 seconds. A background current was not 
subtracted from a signal current. 
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Figure 112. Electrochemical determination of non-glycated Hb and GHb after elution 
from column 2. Data analysis after 50 seconds. A background current was not 
subtracted from a signal current. 
 
Table 28. HbA1c (%) in ClinCheck control, level I and II determined by 
electrochemical detection. Separation of GHb on Column1. 
  HbA1c (%) in ClinCheck control, level I 
Analysis of 
electrochemical signal 
GHb, Total Hb 
non-glycated 
Hb, GHb 
non-glycated 
Hb, Total Hb 
mg/mL (calibration 
curve) 
11.3 9.1 
 
i (A) 13.8 10.8 
 
 
HbA1c (%) in ClinCheck control, level II 
mg/mL  
(calibration curve) 
7.4 9.5 24.6 
i (A) 9.9 12.0 23.0 
 
Table 29. HbA1c (%) in ClinCheck control, level I and II determined by 
electrochemical detection. Separation of GHb on Column2. 
  HbA1c (%) in ClinCheck control, level I 
Analysis of  
electrochemical signal 
GHb, Total Hb 
non-glycated 
Hb, GHb 
non-glycated 
Hb, Total Hb 
mg/mL (calibration 
curve) 
13.6 9.9 - 
i (A) 15.8 11.3 - 
  HbA1c (%) in ClinCheck control, level II 
mg/mL (calibration 
curve) 
13.5 11.9 3.4 
i (A) 15.3 13.1 3.3 
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The increased level of HbA1c (Level I) in comparison to the data provided by the 
supplier might results from uncontrolled processes running on screen printed electrodes 
over a longer time. Theoretically, concentration of Hb in samples was within a detection 
limit. However, a calibration curve should be of hight quality to detect a very small 
variation. Detection should be improved to determine very small differences between 
normal and abnormal level of HbA1c in that configuration. 
 
Longer pre-incubation time (1 and 5 minutes) was also tested. However it did not 
improve sensitivity. Detection of Hb was also conducted in the FIA system. Injected 
samples containing HQ, H202 and total Hb or non-glycated Hb were analysed.  Results 
showed no difference between these Hb samples.  
10.2.2.3 Separation of GHb from non-glycated Hb by affinity 
chromatography – FIA system 
Further work was focussed on separation of GHb from non-glycated Hb performed on a 
chromatographic column combined with electrochemical detection in the flow system. 
The GHb (%) was determined on the basis of peak area of non-glycated Hb and GHb. 
HbA1c (%) was calculated from the algorithm. Clincheck, Helena control samples and 
blood specimens were analysed. 
 
The HbA1c (%) in ClinCheck control samples, level I and II amounted to 10.3 and 17.2 
%, respectively (Figure 113). 7.4% HbA1c was detected in blood samples (Figure 114). 
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Figure 113. Chromatogram of ClinCheck control samples and electrochemical detection 
of non-glycated Hb (first peak) and GHb (second peak) fractions. The arrow indicates a 
change of buffer. 
 
 
Figure 114. Chromatogram of a blood sample and electrochemical detection of non-
glycated Hb (first peak) and GHb (second peak) fractions. The arrow indicates a change 
of buffer. 
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The Glyco-Tek Abnormal Control was used to determine different concentration of Hb 
(Figures 115-118). Samples contained the same percentage of HbA1c. Results for 
Glyco-Tek Normal and Abnormal Controls are shown in the Table 30. Non-glycated Hb 
was detected in a range from 1.83 to 11 mg/mL and GHb from 0.4 to 2.4 mg/mL 
(Figures 116-118). 
 
Table 30. HbA1c (%) determined by affinity chromatography combined with 
electrochemical detection in the flow system. 
Glyco-Tek 
Abnormal 
Control 
non-glycated Hb GHb HbA1c 
HbA1c  
(average) 
mg/mL % 
1.83 0.4 27.1 
23.2 
3.66 0.8 21.4 
7.32 1.6 22.9 
10.98 2.4 19.9 
14.64 3.2 24.7 
Glyco-Tek 
Normal 
analysis of GHb, non-glycated Hb 
(electrochemical signal) 
 
6.5 
  
GHb, non-glycated Hb (mg/mL) 
read from calibration curve 
 
1.7 
  
 
 
Figure 115. Separation of non-glycated Hb from GHb (Glyco-Tek Abnormal Control) 
on the affinity column and its electrochemical detection at -400 mV on SPE-D1 
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Figure 116. Detection of non-glycated Hb separated from GHb (Helena Abnormal 
Control) by affinity chromatography combined with electrochemical detection on SPE-
D1 at a potential -400 mV in the FIA system.  
 
 
Figure 117. Separation of GHb from non-glycated Hb (Glyco-Tek Abnormal Control) 
on the affinity column and its electrochemical detection at -400 mV on SPE-D1. 
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Figure 118. Detection of GHb separated from non-glycated Hb (Helena Abnormal 
Control) by affinity chromatography combined with electrochemical detection on SPE-
D1 at a potential -400 mV in the FIA system.  
 
The chromatogram of blood samples spiked with a known concentration of HbA1c 
showed a lower current signal compared to the chromatograph of control samples 
(Figures 118 and 121). It may be attributed to a stabiliser that was presented in Glyco-
Tek controls. That could explain a much higher amount of HbA1c (%) in Glyco-Tek 
Abnormal control samples compared to data provided by the producer (Table 30). The 
presence of interferences caused by substances such as ascorbic acid, acethaminophen 
and uric acid could also decrease response of Hb. 5.2 % of HbA1c was determined in 
blood samples by the multiple standard addition method (Figure 121).  
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Figure 119. Separation of GHb from non-glycated Hb on the affinity column and its 
electrochemical detection at -400 mV on SPE-D2. Blood samples were spiked with a 
known concentration of HbA1c. 
 
 
Figure 120. Separation of GHb from non-glycated Hb on the affinity column and its 
electrochemical detection at -400 mV on SPE-D2. Blood samples were spiked with a 
known concentration of HbA1c. 
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Figure 121. Detection of GHb separated from non-glycated Hb by affinity 
chromatography combined with electrochemical detection on SPE-D2 at a potential -
400 mV in the FIA system. Blood samples containing GHb (0.4 mg/mL) spiked with 
HbA1c (standard solution). 
 
Chromatographic separations and sensor response was verified against the Glyco-Tek 
Affinity Column Method and the correlation was obtained with R
2
 = 0.9945 (Figure 
122). Electrochemical detection was also verified against data provided by the producer 
of control samples. Helena Normal and Abnormal level analysed by the Glyco-Tek 
Affinity Column Method and ClinCheck controls verified by HPLC (HPLC RECIPE) or 
immunologic method (Bayer / Siemens) gave the correlation R
2
 = 0.9254 and R
2
 = 
0.981, respectively (Figures 123 and 124). 
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Figure 122. Electrochemical detection of HbA1c verified against spectrophotometric 
determination. Control samples: Helena Normal and Abnormal level of HbA1c, 
ClinCheck controls – level I and II and blood samples were analysed. 
 
 
Figure 123. Electrochemical detection of HbA1c verified against data provided by the 
producer. Control samples: Helena Normal and Abnormal level of HbA1c (GLYCO-
Tek Affinity Column Method), ClinCheck controls – level I and II (HPLC RECIPE). 
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Figure 124. Electrochemical detection of HbA1c verified against data provided by the 
producer. Control samples: Helena Normal and Abnormal level of HbA1c (GLYCO-
Tek Affinity Column Method), ClinCheck controls – level I and II (Bayer / Siemens – 
immunologic method). 
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10.3 Conclusions 
There is still a necessity to perform more laboratory trials for HbA1c determination, 
with different level of HbA1c (blood samples) and compare them with validated 
laboratory reference method that is certified by NGSP (Gallagher et al., 2009, 
http://www.ngsp.org). 
 
However, promising results and a good correlation of studied system as compared with 
other methods suggest a possibility to construct a novel device for HbA1c 
determination. So far there is no successful HbA1c sensor on the market based on 
electrochemical detection. The reason may be a complicated procedure necessary to 
follow and a high cost of a device. This chapter demonstrated development of a 
relatively simple system. Comparison of non-glycated haemoglobin and glycated 
haemoglobin (one injected sample) without requirement of precise collection, dilution 
and injection of sample may facilitate procedure of HbA1c determination.  A device 
should be easy to use by unqualified person to avoid errors caused by manual 
operations. This is one of the major problems encountered when point of care devices 
are used in a busy clinics, for example A1C Now (Metrica) device generated an 
abnormal value of HbA1c as a result of reduced volume (50%) of blood samples or 
diluted samples, NycoCard (Axis-Shield) produced inaccurate results for increased 
volume (50%) of blood samples (John et al., 2006). An attempt could be made in the 
future to use results obtained in this work to design a point-of-care device, a benchtop or 
a microfluidic device.  
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Chapter 11:  Final conclusions 
The main objectives of this project were achieved during research on development of 
HbA1c sensor. Two approaches for electrochemical detection of haemoglobin were 
successfully developed. Novel approach based on enzymatic activity of haemoglobin 
was applied for studies focused on recognition of HbA1c.  
 
Binding of haemoglobin was substantially higher on MIP in comparison to NIP polymer 
(both prepared on the microplate surface). However, preparation of efficient MIP - 
based sensor is still a challenge, especially to detect a large, similar protein in a complex 
medium, such as blood. Therefore boronic affinity materials, which are commonly used 
in diagnostic of HbA1c, were studied to evaluate a plausible integration with an 
electrochemical device capable of determining HbA1c in blood samples.  
 
It was possible to distinguish normal and abnormal levels of HbA1c by boronic acid 
affinity chromatography combined with electrochemical detection in a FIA system. 
Sensor response showed a good correlation with spectrophotometric detection, and with 
data provided by a producer of control blood samples which were analyzed by methods, 
such as HPLC and immunochemistry. The system is relatively cheap, fast and simple, 
which is required to introduce a device on the market. Determination of HbA1c (%) on 
the basis of the electrochemical signal of non-glycated haemoglobin and total glycated 
haemoglobin (GHb) may facilitate the construction of an easier-to-use point of care 
device.  Precise collection of a blood specimen may be not required and the protocol 
will be easier to follow by non-medical personnel. Point of care devices, currently 
available on the market are difficult to operate and there is a need to improve sensitivity 
and repeatability to detect very small variations in HbA1c in blood specimens. In order 
to yield good results, the affinity column and electrodes must be of high quality.  
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